Zscaler (ZS) 10-K 12 Sep 24 2024 FY Annual report Financial data

Cover Page

Cover Page - USD ($) $ in Billions	12 Months Ended
	Jul. 31, 2024	Aug. 30, 2024	Jan. 31, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jul. 31, 2024
Current Fiscal Year End Date	--07-31
Document Transition Report	false
Entity File Number	001-38413
Entity Registrant Name	ZSCALER, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	26-1173892
Entity Address, Address Line One	120 Holger Way
Entity Address, City or Town	San Jose
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	408
Local Phone Number	533-0288
Title of 12(b) Security	Common Stock, $0.001 Par Value
Trading Symbol	ZS
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error Correction [Flag]	false
Entity Shell Company	false
Entity Public Float			$ 19.8
Shares Outstanding		152,490,005
Documents Incorporated by Reference	Portions of the registrant’s definitive Proxy Statement relating to its fiscal year 2024 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K where indicated. Such Proxy Statement will be filed with the United States Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Annual Report on Form 10-K relates.
Entity Central Index Key	0001713683
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Jul. 31, 2024
Audit Information [Abstract]
Auditor Firm ID	238
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	San Jose, California

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Current assets:
Cash and cash equivalents	$ 1,423,080	$ 1,262,206
Short-term investments	986,574	838,026
Accounts receivable, net	736,529	582,636
Deferred contract acquisition costs	148,873	115,827
Prepaid expenses and other current assets	101,561	91,619
Total current assets	3,396,617	2,890,314
Property and equipment, net	383,121	242,355
Operating lease right-of-use assets	89,758	70,671
Deferred contract acquisition costs, noncurrent	296,525	259,407
Acquired intangible assets, net	63,835	25,859
Goodwill	417,029	89,192
Other noncurrent assets	58,083	30,519
Total assets	4,704,968	3,608,317
Current liabilities:
Accounts payable	23,309	18,481
Accrued expenses and other current liabilities	91,708	64,975
Accrued compensation	160,810	136,800
Deferred revenue	1,643,919	1,281,143
Convertible senior notes	1,142,275	0
Operating lease liabilities	50,866	34,469
Total current liabilities	3,112,887	1,535,868
Convertible senior notes, noncurrent	0	1,134,159
Deferred revenue, noncurrent	251,055	158,533
Operating lease liabilities, noncurrent	44,824	41,917
Other noncurrent liabilities	22,100	12,728
Total liabilities	3,430,866	2,883,205
Commitments and contingencies (Note 12)
Stockholders’ Equity
Preferred stock; $0.001 par value; 200,000 shares authorized as of July 31, 2024 and 2023, respectively; no shares issued and outstanding as of July 31, 2024 and 2023	0	0
Common stock; $0.001 par value; 1,000,000 shares authorized as of July 31, 2024 and 2023, respectively; 152,490 and 147,169 shares issued and outstanding as of July 31, 2024 and 2023, respectively	152	147
Additional paid-in capital	2,426,819	1,816,915
Accumulated other comprehensive loss	(4,789)	(1,576)
Accumulated deficit	(1,148,080)	(1,090,374)
Total stockholders’ equity	1,274,102	725,112
Total liabilities and stockholders’ equity	$ 4,704,968	$ 3,608,317

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jul. 31, 2024	Jul. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	200,000,000	200,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	152,490,000	147,169,000
Common stock, shares outstanding (in shares)	152,490,000	147,169,000

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Income Statement [Abstract]
Revenue	$ 2,167,771	$ 1,616,952	$ 1,090,946
Cost of revenue	477,129	362,832	242,282
Gross profit	1,690,642	1,254,120	848,664
Operating expenses:
Sales and marketing	1,100,239	953,864	735,219
Research and development	499,828	349,735	289,139
General and administrative	212,052	177,544	151,735
Restructuring and other charges	0	7,600	0
Total operating expenses	1,812,119	1,488,743	1,176,093
Loss from operations	(121,477)	(234,623)	(327,429)
Interest income	109,130	60,462	4,586
Interest expense	(13,132)	(6,541)	(56,579)
Other expense, net	(3,750)	(1,862)	(4,208)
Loss before income taxes	(29,229)	(182,564)	(383,630)
Provision for income taxes	28,477	19,771	6,648
Net loss	$ (57,706)	$ (202,335)	$ (390,278)
Net loss per share, basic (in dollars per share)	$ (0.39)	$ (1.40)	$ (2.77)
Net loss per share, diluted (in dollars per share)	$ (0.39)	$ (1.40)	$ (2.77)
Weighted-average shares used in computing net loss per share, basic (in shares)	149,586	144,942	140,895
Weighted-average shares used in computing net loss per share, diluted (in shares)	149,586	144,942	140,895

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (57,706)	$ (202,335)	$ (390,278)
Available-for-sale securities:
Change in net unrealized gains (losses) on available-for-sale securities	9,948	1,592	(12,083)
Cash flow hedging instruments:
Change in net unrealized gains (losses)	(10,761)	11,103	(20,130)
Net realized (gains) losses reclassified into net loss	(2,400)	11,579	7,013
Net change on cash flow hedges	(13,161)	22,682	(13,117)
Other comprehensive income (loss)	(3,213)	24,274	(25,200)
Comprehensive loss	$ (60,919)	$ (178,061)	$ (415,478)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance (in shares) at Jul. 31, 2021			138,662
Beginning balance at Jul. 31, 2021	$ 528,895		$ 139	$ 1,131,006		$ (650)	$ (601,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)			905
Issuance of common stock upon exercise of stock options	6,943			6,943
Issuance of common stock under the employee stock purchase plan (in shares)			319
Issuance of common stock under the employee stock purchase plan	34,649			34,649
Vesting of restricted stock units, performance stock awards and other stock issuances (in shares)			3,152
Vesting of restricted stock units, performance stock awards and other stock issuances	1,703		$ 4	1,699
Stock-based compensation	416,588			416,588
Other comprehensive income (loss)	(25,200)					(25,200)
Net loss	(390,278)						(390,278)
Ending balance (in shares) at Jul. 31, 2022			143,038
Ending balance at Jul. 31, 2022	$ 573,300	$ (169,899)	$ 143	1,590,885	$ (273,738)	(25,850)	(991,878)	$ 103,839
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2020-06 [Member]
Issuance of common stock upon exercise of stock options (in shares)			451
Issuance of common stock upon exercise of stock options	$ 3,944			3,944
Issuance of common stock under the employee stock purchase plan (in shares)			425
Issuance of common stock under the employee stock purchase plan	42,263			42,263
Vesting of restricted stock units, performance stock awards and other stock issuances (in shares)			3,255
Vesting of restricted stock units, performance stock awards and other stock issuances	0		$ 4	(4)
Stock-based compensation	453,565			453,565
Other comprehensive income (loss)	24,274					24,274
Net loss	$ (202,335)						(202,335)
Ending balance (in shares) at Jul. 31, 2023	147,169		147,169
Ending balance at Jul. 31, 2023	$ 725,112		$ 147	1,816,915		(1,576)	(1,090,374)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	864		864
Issuance of common stock upon exercise of stock options	$ 12,249			12,249
Issuance of common stock under the employee stock purchase plan (in shares)			489
Issuance of common stock under the employee stock purchase plan	51,998			51,998
Vesting of restricted stock units, performance stock awards and other stock issuances (in shares)			3,624
Vesting of restricted stock units, performance stock awards and other stock issuances	0		$ 5	(5)
Issuance of restricted shares of common stock in connection with business acquisitions subject to future vesting (in shares)			344
Issuance of replacement awards attributable to pre-combination vesting in connection with business acquisitions	3,805			3,805
Stock-based compensation	541,857			541,857
Other comprehensive income (loss)	(3,213)					(3,213)
Net loss	$ (57,706)						(57,706)
Ending balance (in shares) at Jul. 31, 2024	152,490		152,490
Ending balance at Jul. 31, 2024	$ 1,274,102		$ 152	$ 2,426,819		$ (4,789)	$ (1,148,080)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Cash Flows From Operating Activities
Net loss	$ (57,706)	$ (202,335)	$ (390,278)
Adjustments to reconcile net loss to cash provided by operating activities:
Depreciation and amortization expense	66,308	55,756	40,456
Amortization expense of acquired intangible assets	14,624	11,060	9,010
Amortization of deferred contract acquisition costs	130,139	98,718	68,531
Amortization of debt issuance costs	3,914	3,894	55,141
Non-cash operating lease costs	49,445	32,212	25,626
Stock-based compensation expense	527,676	444,834	409,562
Amortization (accretion) of investments purchased at a premium (discount)	(19,062)	(6,582)	6,580
Unrealized (gains) losses on hedging transactions	753	(3,319)	1,499
Deferred income taxes	(5,633)	352	(562)
Other	3,320	(820)	(1,104)
Changes in operating assets and liabilities, net of effects of business combinations:
Accounts receivable	(152,960)	(183,858)	(143,336)
Deferred contract acquisition costs	(200,303)	(176,950)	(158,503)
Prepaid expenses, other current and noncurrent assets	(39,971)	(39,922)	(10,287)
Accounts payable	4,164	(8,416)	14,358
Accrued expenses, other current and noncurrent liabilities	43,556	26,814	13,377
Accrued compensation	10,507	24,538	18,326
Deferred revenue	450,314	418,564	391,179
Operating lease liabilities	(49,239)	(32,197)	(27,663)
Net cash provided by operating activities	779,846	462,343	321,912
Cash Flows From Investing Activities
Purchases of property, equipment and other assets	(144,588)	(97,197)	(69,296)
Capitalized internal-use software	(50,308)	(31,527)	(21,284)
Payments for business acquisitions, net of cash acquired	(374,702)	(15,643)	(25,287)
Purchase of strategic investments	(2,000)	(3,206)	0
Purchases of short-term investments	(1,291,015)	(1,064,143)	(844,944)
Proceeds from maturities of short-term investments	1,132,268	901,849	1,334,874
Proceeds from sale of short-term investments	47,165	50,530	0
Net cash provided (used) by investing activities	(683,180)	(259,337)	374,063
Cash Flows From Financing Activities
Proceeds from issuance of common stock upon exercise of stock options	12,249	3,944	6,943
Proceeds from issuance of common stock under the employee stock purchase plan	51,998	42,263	34,649
Payment of deferred consideration related to business acquisitions	0	(215)	(250)
Other	(39)	(2)	(5)
Net cash provided by financing activities	64,208	45,990	41,337
Net increase in cash and cash equivalents	160,874	248,996	737,312
Cash and cash equivalents at beginning of period	1,262,206	1,013,210	275,898
Cash and cash equivalents at end of period	1,423,080	1,262,206	1,013,210
Supplemental Disclosure of Cash Flow Information
Cash paid for income taxes, net of tax refunds	23,123	14,940	5,606
Cash paid for interest expense	1,436	1,438	1,438
Non-Cash Activities
Operating lease right-of-use assets obtained in exchange for operating lease obligations, net of terminations	64,700	29,129	51,962
Equity consideration for business acquisitions	3,805	0	0
Net change in purchased equipment included in accounts payable and accrued expenses	$ 1,111	$ 1,588	$ (997)

Business and Summary of Signifi

Business and Summary of Significant Accounting Policies	12 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Business and Summary of Significant Accounting Policies	Business and Summary of Significant Accounting Policies Description of the Business Zscaler, Inc. ("Zscaler," the "Company," "we," "us," or "our") is a cloud security company that developed a platform incorporating core security functionalities needed to enable fast and secure access to cloud resources based on identity, context and organization’s policies. Our solution is a purpose-built, multi-tenant, distributed cloud platform that incorporates the security functionality needed to enable users, applications, and devices to safely and efficiently utilize authorized applications and services based on an organization’s business policies. We deliver our solutions using a software-as-a-service ("SaaS") business model and sell subscriptions to customers to access our cloud platform, together with related support services. We were incorporated in Delaware in September 2007 and conduct business worldwide, with presence in North America, Europe and Asia. Our headquarters are in San Jose, California. Fiscal Year Our fiscal year ends on July 31. References to fiscal 2024, for example, refer to our fiscal year ending July 31, 2024. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries and have been prepared in conformity with generally accepted accounting principles in the United States ("GAAP"). All intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the consolidated financial statements. Due to uncertainty in the macroeconomic environment, including the effects of inflation and geopolitical events, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained. Foreign Currency The functional currency of our foreign subsidiaries is the U.S. dollar. Accordingly, monetary assets and liabilities of our foreign subsidiaries are re-measured into U.S. dollars at the exchange rates in effect at the reporting date, non-monetary assets and liabilities are re-measured at historical rates, revenue and expenses are re-measured at average exchange rates in effect during each reporting period. Foreign currency transaction gains and losses are recorded in other expense, net in the consolidated statements of operations. Foreign currency remeasurement gains and losses and foreign currency transaction gains and losses are not significant to the consolidated financial statements for all periods presented. Concentration of Risks We generate revenue primarily from sale of subscriptions to access our cloud platform, together with related support services. Our sales team, along with our channel partner network of global telecommunications service providers, system integrators and value-added resellers (collectively "channel partners"), sells our services worldwide to organizations of all sizes. Due to the nature of our services and the terms and conditions of our contracts with our channel partners, our business could be affected unfavorably if we are not able to continue our relationships with them. Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents, derivative contracts, short-term investments and accounts receivable. Although we deposit our cash with multiple financial institutions, the deposits, at times, may exceed federally insured limits. Cash equivalents and short-term investments consist of highly liquid investments in money market funds, U.S. treasury, U.S. agency securities, certificates of deposit and corporate debt securities, which are invested through financial institutions. We grant credit to our customers in the normal course of business. We monitor the financial condition of our customers to reduce credit risk. Refer to Note 2, Revenue Recognition, for information regarding customers with concentration of 10% or more of the total balance of accounts receivable, net. Segment Information We operate as one reportable and operating segment. Our chief operating decision maker is our chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance and allocating resources. Revenue Recognition In accordance with Accounting Standards Codification ("ASC") Topic 606, Revenue From Contracts With Customers ("ASC 606"), revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration that we expect to be entitled to receive in exchange for these services. To achieve the core principle of this standard, we apply the following five steps: 1) Identify the contract with a customer We consider the terms and conditions of the contracts and our customary business practices in identifying our contracts under ASC 606. We determine we have a contract with a customer when the contract is approved, we can identify each party’s rights regarding the services to be transferred, we can identify the payment terms for the services, we have determined the customer has the ability and intent to pay and the contract has commercial substance. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information pertaining to the customer. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. Our performance obligations consist of (i) our subscription and support services and (ii) professional and other services. 3) Determine the transaction price The transaction price is determined based on the consideration to which we expect to be entitled in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of our contracts contain a significant financing component. 4) Allocate the transaction price to performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). 5) Recognize revenue when or as we satisfy a performance obligation Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised service to a customer. Revenue is recognized when control of the services is transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those services. We generate all our revenue from contracts with customers and apply judgment in identifying and evaluating any terms and conditions in contracts which may impact revenue recognition. Subscription and Support Revenue We generate revenue primarily from sales of subscriptions to access our cloud platform, together with related support services to our customers. Arrangements with customers do not provide the customer with the right to take possession of our software operating our cloud platform at any time. Instead, customers are granted continuous access to our cloud platform over the contractual period. A time-elapsed output method is used to measure progress because we transfer control evenly over the contractual period. Accordingly, the fixed consideration related to subscription and support revenue is generally recognized on a straight-line basis over the contract term beginning on the date that our service is made available to the customer. The typical subscription and support term is one Professional and Other Services Revenue Professional and other services revenue consists of fees associated with providing deployment advisory services that educate and assist our customers on the best use of our solutions, as well as advise customers on best practices as they deploy our solution. These services are distinct from subscription and support services. Professional services do not result in significant customization of the subscription service. Revenue from professional services provided on a time and materials basis is recognized as the services are performed. Total professional and other services revenue has historically not been material. Contracts with Multiple Performance Obligations Most of our contracts with customers contain multiple promised services consisting of: (i) our subscription and support services and (ii) professional and other services that are distinct and accounted for separately. The transaction price is allocated to the separate performance obligations on a relative SSP basis. We determine SSP based on our overall pricing objectives, taking into consideration the type of subscription and support services and professional and other services, the geographical region of the customer and the number of users. Variable Consideration Revenue from sales is recorded at the net sales price, which is the transaction price, and includes estimates of variable consideration. The amount of variable consideration that is included in the transaction price is constrained and included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue will not occur when the uncertainty is resolved. If our services do not meet certain service level commitments, our customers are entitled to receive service credits, and in certain cases, refunds, each representing a form of variable consideration. We have historically not experienced any significant incidents affecting the defined levels of reliability and performance as required by our subscription contracts. Accordingly, estimated refunds related to these agreements were not material to the periods presented. We provide rebates and other credits within our contracts with certain customers, which are estimated based on the value expected to be earned or claimed on the related sales transaction. Overall, the transaction price is reduced to reflect our estimate of the amount of consideration to which we are entitled based on the terms of the contract. Estimated rebates and other credits were not material during the periods presented. Accounts Receivable and Allowance Accounts receivable are recorded at the invoiced amount and are non-interest bearing. Accounts receivable are stated at their net realizable value, net of an allowance for doubtful accounts. We have a well-established collections history from our customers. Credit is extended to customers based on an evaluation of their financial condition and other factors. In determining the necessary allowance for doubtful accounts, we estimate the lifetime expected credit losses against the existing accounts receivable balance. Our estimate is based on certain factors including historical loss rates, current economic conditions, reasonable and supportable forecasts and customer-specific circumstances. The allowance for doubtful accounts has historically not been material. There were no material write-offs recognized in the periods presented. Accordingly, the movements in the allowance for doubtful accounts were not material for any of the periods presented. We do not have any off-balance-sheet credit exposure related to our customers. Cash Equivalents and Short-Term Investments We classify all highly liquid investments purchased with an original maturity of 90 days or less from the date of purchase as cash equivalents and all highly liquid investments with original maturities beyond 90 days at the time of purchase as short-term investments. Our cash equivalents and short-term investments consist of highly liquid investments in money market funds, U.S. treasury securities, U.S. government agency securities, certificates of deposit and corporate debt securities. We classify our investments as available-for-sale investments and present them within current assets since these investments represent funds available for current operations and we have the ability and intent, if necessary, to liquidate any of these investments in order to meet our liquidity needs or to grow our business, including for potential business acquisitions or other strategic transactions. Our investments are carried at fair value, with unrealized gains and losses unrelated to credit loss factors reported in accumulated other comprehensive income (loss) ("AOCI"). Our investments are reviewed periodically when there is a decline in a security’s fair value below the amortized cost basis. We consider our intent to sell and whether it is more likely than not that we will be required to sell the securities before the recovery of its cost basis. If either of these criteria are triggered, the amortized cost basis of the debt security is written down to fair value through other expense, net. If neither criteria is met, we evaluate whether the decline in fair value below the amortized cost basis is related to credit-related factors or other factors such as interest rate fluctuations. The factors considered in this analysis include the extent the fair value is less than the amortized cost basis, whether there were changes to the rating of the security by a ratings agency, whether the issuer has failed to make scheduled interest payments and other adverse conditions as applicable. Credit-related impairment losses, limited by the amount that the fair value is less than the amortized cost basis, are recorded through an allowance for credit losses in other expense, net. For purposes of identifying and measuring credit-related impairments, our policy is to exclude the applicable accrued interest from both the fair value and amortized cost basis of the related debt security. Accrued interest receivable, net of the allowance for credit losses, if any, is recorded to prepaid expenses and other current assets. There were no credit-related impairments recognized on our investments during the periods presented. Interest income, amortization (accretion) of investments purchased at a premium (discount) and realized gains and losses are included in interest income in the consolidated statements of operations. We use the specific identification method to determine the cost in calculating realized gains and losses upon the sale of these investments. Strategic Investments Our strategic investments consist of non-marketable equity investments of privately held companies. Investments in non-marketable equity investments of privately held companies without readily determinable fair values are measured using the measurement alternative, as we have less than 20% ownership and do not have the ability to exercise significant influence over their operations. The carrying amount of non-marketable equity investments is adjusted based on observable price changes from orderly transactions for identical or similar investments of the same issuer and by impairments when events or circumstances indicate a decline in value has occurred. Non-marketable equity investments that have been remeasured during the period due to an observable event or impairment are classified within Level 3 in the fair value hierarchy because we estimate the value based on valuation methods which may include a combination of the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the investments we hold. Our strategic investments are included within other noncurrent assets in the consolidated balance sheets and adjustments to their carrying amounts are recorded in other expense, net in the consolidated statements of operations. There were no material events or circumstances impacting the carrying amount of our strategic investments during the periods presented. Fair Value of Financial Instruments Our financial instruments consist of cash equivalents, short-term investments, accounts receivable, accounts payable, accrued liabilities, derivative instruments and convertible senior notes. Cash e quivalents and short-term investments are recorded at fair value. Accounts receivable, accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short-time to the expected receipt or payment date. Assets recorded at fair value on a recurring basis in the consolidated balance sheets, consisting of cash equivalents and short-term investments, are categorized in accordance with the fair value hierarchy based upon the level of judgment associated with the inputs used to measure their fair values. We carry the convertible senior notes at face value less debt issuance costs and hedge accounting fair value adjustments on our consolidated balance sheet. The fair value of the convertible senior notes is presented at each reporting period for disclosure purposes only. Property and Equipment Property and equipment, net are stated at historical cost net of accumulated depreciation. Property and equipment, excluding leasehold improvements, are depreciated using the straight-line method over the estimated useful lives of the respective assets, generally ranging from three In August 2023, we completed an assessment of the useful lives of our servers and networking equipment, which resulted in an extension of their useful lives from four Capitalized Internal-Use Software We capitalize certain costs incurred during the application development stage in connection with software development for our cloud security platform. Costs related to preliminary project activities and post-implementation activities are expensed as incurred. Capitalized costs are recorded as part of property and equipment in the consolidated balance sheets. Maintenance and training costs are expensed as incurred. Capitalized internal-use software is amortized on a straight-line basis over its estimated useful life, which is generally three Business Combinations We account for our business combinations using the acquisition method of accounting, which requires, among other things, allocation of the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, we make estimates and assumptions, especially with respect to intangible assets. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, we may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill if new information is obtained related to facts and circumstances that existed as of the acquisition date. After the measurement period, any subsequent adjustments are reflected in the consolidated statements of operations. Acquisition costs, such as legal and consulting fees, are expensed as incurred. Goodwill and Other Long-Lived Assets, including Acquired Intangible Assets Goodwill represents the excess of the fair value of purchase consideration in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill amounts are not amortized, but rather tested for impairment at least annually or more often if circumstances indicate that the carrying value may not be recoverable. There was no impairment of goodwill during any of the periods presented. Acquired intangible assets consist of identifiable intangible assets, including developed technology and customer relationships, resulting from business combinations. Acquired finite-lived intangible assets are initially recorded at fair value and are amortized on a straight-line basis over their estimated useful lives. Amortization expense of developed technology and customer relationships is recorded primarily within cost of revenues and sales and marketing expenses, respectively, in the consolidated statements of operations. Long-lived assets, such as property and equipment and acquired intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows that these assets are expected to generate. If the total of the future undiscounted cash flows are less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds the fair value. There were no asset impairments for all periods presented. Restructuring and Other Charges Restructuring and other charges occur when we commit to a restructuring plan, the restructuring plan identifies all significant actions, the period of time to complete the restructuring plan indicates that significant changes to the restructuring plan are not likely and employees who are impacted have been notified of the pending involuntary termination. A restructuring plan generally includes significant actions involving employee-related severance charges, employee-related benefits, stock-based compensation expense related to the modification of equity incentive awards and other charges associated with the restructuring (the "restructuring charges"). Restructuring charges are accrued in the period in which it is probable that the employees are entitled to the restructuring benefits and the amounts can be reasonably estimated. Restructuring charges are recorded within restructuring and other charges in the consolidated statement of operations. The restructuring liability accrued but not paid at the end of the reporting period is included within accrued compensation in the consolidated balance sheets. Derivative Instruments We enter into foreign currency forward contracts, a portion of which we designate as cash flow hedges, in order to manage the volatility of cash flows that relate to our cost of revenues and operating expenses denominated in foreign currencies. We also use interest rate swaps to economically convert a certain tranche of our fixed interest rate convertible senior notes to floating interest rates, in order to match the floating rate nature of a portion of our cash, cash equivalents, and short-term investments. These interest rate swaps are designated as fair value hedges, and changes in fair value of the interest rate swaps offset the changes in fair market value of the convertible senior notes due to benchmark interest rate movements. Gains or losses related to our fair value hedges are included within interest expense in the consolidated statement of operations in the period of change together with the offsetting loss or gain on the hedged item attributed to the risk being hedged. We measure hedge effectiveness of the interest rate swaps using regression analysis at inception and periodically thereafter. Gains or losses related to our cash flow hedges are recorded as a component of AOCI in the consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within the financial statement line item associated with the underlying hedged transaction. We measure hedge effectiveness using regression analysis at hedge inception and periodically thereafter. We include time value in our effectiveness assessment. We recognize changes in the fair value of non-designated derivative instruments within other expense, net in the consolidated statements of operations in the same period that the fair value measurement occurs. All of our derivative instruments are measured at fair value. We have elected to present the derivative assets and derivative liabilities on a gross basis on the consolidated balance sheets. Derivative instruments are classified in the consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions. Operating Leases We enter into operating lease arrangements for real estate assets related to office space and co-location assets related to space and racks at data center facilities. We determine if an arrangement contains a lease at its inception by assessing whether there is an identified asset and whether the arrangement conveys the right to control the use of the identified asset in exchange for consideration. Operating leases related balances are included in "operating lease right-of-use assets," "operating lease liabilities," and "operating lease liabilities, noncurrent" in the consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make payments arising from the lease. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments consist of the fixed payments under the arrangement. The operating lease liabilities are adjusted for any unpaid lease incentives, such as tenant improvement allowances. Variable costs, such as maintenance and utilities based on actual usage, are not included in the measurement of right-to-use assets and lease liabilities but are expensed when the event determining the amount of variable consideration to be paid occurs. As the implicit rate of our leases is not determinable, we use an incremental borrowing rate ("IBR") based on the information available at the lease commencement date in determining the present value of lease payments. The lease expense is recognized on a straight-line basis over the lease term. We generally use the base, non-cancelable lease term when recognizing the right-of-use assets and lease liabilities, unless it is reasonably certain that a renewal or termination option will be exercised. We account for lease components and non-lease components as a single lease component. Leases with a term of twelve months or less are not recognized on the consolidated balance sheets. Stock-Based Compensation Compensation expense related to stock-based awards granted to employees and non-employees is calculated based on the fair value of stock-based awards on the date of grant. We recognize stock-based compensation expense in the consolidated statement of operations over an award’s requisite service period based on the award’s fair value. Stock-based compensation for common stock options is measured based on the fair value of the awards granted, determined using the Black-Scholes option pricing model. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period, generally four years. Stock-based compensation for purchase rights granted under the employee stock purchase plan ("ESPP") is measured based on the fair value of the number of awards estimated at the beginning of the offering period, as determined using the Black-Scholes option pricing model. Stock-based compensation expense is recognized on a straight-line basis over the two-year offering period. Stock-based compensation for restricted stock units ("RSUs") with only service conditions is measured based on the market closing price of our common stock on the grant date. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period, generally four years. Stock-based compensation for performance stock awards (“PSAs”), which have the same grant date and service inception date, and subject to both service and performance conditions, is measured based on the probable number of shares to be attained and the market closing price of our common stock at the grant date. The expense is recognized using the accelerated attribution method over the requisite service period. For PSAs where the service inception date of the awards precedes the grant date, stock-based compensation expense is recognized based on the number of PSAs for which it is probable that the performance condition will be met, using the accelerated attribution method and the market closing price of our common stock at each reporting date up to the grant date. The number of these PSAs for which it is probable that the performance condition will be met is determined using management’s best estimate at the end of each reporting period. At the completion of the performance period for these PSAs, any earned PSAs are granted upon approval of the compensation committee of our board of directors. We account for forfeitures as they occur for all stock-based awards. Convertible Senior Notes We adopted Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06") as of August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. Prior to the adoption of ASU 2020-06, in accounting for the issuance of the convertible senior notes, the convertible senior notes were separated into liability and equity components. The carrying amounts of the liability component was calculated by measuring the fair value of similar liabilities that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the convertible senior notes as a whole. This difference represents the debt discount that was amortized to interest expense over the respective terms of the convertible senior notes using the effective interest rate method. The equity component was recorded in additional paid-in capital and was not remeasured as long as it continu

Revenue Recognition

Revenue Recognition	12 Months Ended
	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Subscription and support revenue is recognized over time and accounted for approximately 97% of our revenue for each of fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Year Ended July 31, 2024 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) United States $ 1,092,304 50 % $ 808,527 50 % $ 536,924 49 % Europe, Middle East and Africa 672,421 31 515,136 32 370,035 34 Asia Pacific 327,816 15 241,250 15 155,460 14 Other 75,230 4 52,039 3 28,527 3 Total $ 2,167,771 100 % $ 1,616,952 100 % $ 1,090,946 100 % ____ The following table summarizes the revenue from contracts by type of customer: Year Ended July 31, 2024 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) Channel partners $ 1,967,908 91 % $ 1,488,379 92 % $ 1,016,747 93 % Direct customers 199,863 9 128,573 8 74,199 7 Total $ 2,167,771 100 % $ 1,616,952 100 % $ 1,090,946 100 % Significant Customers No single customer accounted for 10% or more of the total revenue or the total balance of accounts receivable, net in the periods presented. Contract Balances Contract liabilities consist of deferred revenue and include payments received in advance of performance under the contract. Such amounts are recognized as revenue over the contractual period. Deferred revenue, including current and noncurrent balances as of July 31, 2024 and July 31, 2023 was $1,895.0 million and $1,439.7 million, respectively. In fiscal 2024, fiscal 2023 and fiscal 2022 we recognized revenue of $1,277.8 million, $919.9 million and $570.3 million, respectively, that was included in the corresponding contract liability balance at the beginning of the related fiscal year. We receive payments from customers based upon contractual billing schedules and accounts receivable are recorded when the right to consideration becomes unconditional. Payment terms on invoiced amounts are typically 30 days but may be up to 90 days for some of our channel partners. Contract assets include amounts related to our contractual right to consideration for both completed and partially completed performance obligations that may not have been invoiced and such amounts have historically not been material. Remaining Performance Obligations The typical subscription and support term is one Costs to Obtain and Fulfill a Contract We capitalize sales commission and associated payroll taxes paid to sales personnel that are incremental to the acquisition of channel partner and direct customer contracts. These costs are recorded as deferred contract acquisition costs in the consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans, if the commissions are in fact incremental and would not have occurred absent the customer contract. Sales commissions for renewal of a contract are not considered commensurate with the commissions paid for the acquisition of the initial contract given the substantive difference in commission rates in proportion to their respective contract values. Commissions paid upon the initial acquisition of a contract are amortized over an estimated period of benefit of five years while commissions paid for renewal contracts are amortized over the contractual term of the renewals. Amortization of deferred contract acquisition costs is recognized on a straight-line basis commensurate with the pattern of revenue recognition and included in sales and marketing expense in the consolidated statements of operations. We determine the period of benefit for commissions paid for the acquisition of the initial contract by taking into consideration the expected subscription term and expected renewals of our customer contracts, the duration of our relationships with our customers, customer retention data, our technology development lifecycle and other factors. We periodically review the carrying amount of deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit of these deferred costs. We did not recognize any impairment losses of deferred contract acquisition costs during the periods presented. The activity of the deferred contract acquisition costs consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Beginning balance $ 375,234 $ 297,002 $ 207,030 Capitalization of contract acquisition costs 200,303 176,950 158,503 Amortization of deferred contract acquisition costs (130,139) (98,718) (68,531) Ending balance $ 445,398 $ 375,234 $ 297,002 The outstanding balance of the deferred contract acquisition costs consisted of the following: July 31, 2024 2023 (in thousands) Deferred contract acquisition costs, current $ 148,873 $ 115,827 Deferred contract acquisition costs, noncurrent 296,525 259,407 Total deferred contract acquisition costs $ 445,398 $ 375,234

Cash Equivalents and Short-Term

Cash Equivalents and Short-Term Investments	12 Months Ended
	Jul. 31, 2024
Cash and Cash Equivalents [Abstract]
Cash Equivalents and Short-Term Investments	Cash Equivalents and Short-Term Investments Cash equivalents and short-term investments consisted of the following as of July 31, 2024: Amortized Unrealized Unrealized Fair Value (in thousands) Cash equivalents: Money market funds $ 956,932 $ — $ — $ 956,932 U.S. treasury securities 178,188 — (15) 178,173 U.S. government agency securities 57,555 — (6) 57,549 Certificates of deposit 80,940 — — 80,940 Total cash equivalents $ 1,273,615 $ — $ (21) $ 1,273,594 Short-term investments: U.S. treasury securities $ 257,841 $ 8 $ (828) $ 257,021 U.S. government agency securities 160,574 43 (542) 160,075 Corporate debt securities 568,589 1,514 (625) 569,478 Total short-term investments $ 987,004 $ 1,565 $ (1,995) $ 986,574 Total cash equivalents and short-term investments $ 2,260,619 $ 1,565 $ (2,016) $ 2,260,168 Cash equivalents and short-term investments consisted of the following as of July 31, 2023: Amortized Unrealized Unrealized Fair Value (in thousands) Cash equivalents: Money market funds $ 768,003 $ — $ — $ 768,003 U.S. treasury securities 157,250 — (30) 157,220 U.S. government agency securities 166,671 — (35) 166,636 Corporate debt securities 38,800 — — 38,800 Total cash equivalents $ 1,130,724 $ — $ (65) $ 1,130,659 Short-term investments: U.S. treasury securities $ 175,451 $ — $ (1,875) $ 173,576 U.S. government agency securities 266,392 2 (4,299) 262,095 Corporate debt securities 406,517 49 (4,211) 402,355 Total short-term investments $ 848,360 $ 51 $ (10,385) $ 838,026 Total cash equivalents and short-term investments $ 1,979,084 $ 51 $ (10,450) $ 1,968,685 The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of July 31, 2024: Amortized Fair Value (in thousands) Due within one year $ 476,116 $ 475,325 Due between one to three years 510,888 511,249 Total $ 987,004 $ 986,574 Short-term investments that were in continuous unrealized loss position as of July 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 152,574 $ (115) $ 87,808 $ (713) $ 240,382 $ (828) U.S. government agency securities 65,563 (28) 65,334 (514) 130,897 (542) Corporate debt securities 81,020 (102) 94,666 (523) 175,686 (625) Total $ 299,157 $ (245) $ 247,808 $ (1,750) $ 546,965 $ (1,995) Short-term investments that were in continuous unrealized loss position as of July 31, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 173,576 $ (1,875) $ — $ — $ 173,576 $ (1,875) U.S. government agency securities 119,558 (292) 131,530 (4,007) 251,088 (4,299) Corporate debt securities 232,504 (2,034) 82,599 (2,177) 315,103 (4,211) Total $ 525,638 $ (4,201) $ 214,129 $ (6,184) $ 739,767 $ (10,385) We review the individual securities that have unrealized losses in our short-term investment portfolio on a regular basis. We evaluate, among others, whether we have the intention to sell any of these investments and whether it is not more likely than not that we will be required to sell any of them before recovery of the amortized cost basis. Neither of these criteria were met in any period presented. We additionally evaluate whether the decline in fair value of the corporate debt securities below their amortized cost basis is related to credit losses or other factors. Based on this evaluation, we determined that unrealized losses of the above securities were primarily attributable to changes in interest rates and non credit-related factors. Accordingly, we determined that an allowance for credit losses was unnecessary for our short-term investments as of July 31, 2024 and 2023. As of July 31, 2024 and 2023, we recorded $10.7 million and $7.2 million, respectively, of accrued interest receivable within prepaid expenses and other current assets in the consolidated balance sheets. Strategic Investments Our strategic investments consist primarily of non-marketable equity securities of privately held companies which do not have a readily determinable fair value. These investments are primarily accounted for under the cost method as we have less than 20% ownership and do not have the ability to exercise significant influence over their operations. As of July 31, 2024 and 2023, the carrying amount of our strategic investments was $9.8 million and $7.8 million, respectively, and is included within other noncurrent assets in the consolidated balance sheets. There were no material events or circumstances impacting their carrying amount during the periods presented.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements Fair value is defined as the exchange price that would be received from the sale of an asset or paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. We measure our financial assets and liabilities at fair value at each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. A financial instrument’s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value: • Level I - Observable inputs are unadjusted quoted prices in active markets for identical assets or liabilities; • Level II - Observable inputs are quoted prices for similar assets and liabilities in active markets or inputs other than quoted prices that are observable for the assets or liabilities, either directly or indirectly through market corroboration, for substantially the full term of the financial instruments; and • Level III - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. These inputs are based on our own assumptions used to measure assets and liabilities at fair value and require significant management judgment or estimation. Our money market funds are classified within Level I due to the highly liquid nature of these assets and have quoted prices in active markets. Certain of our investments in available-for-sale securities (i.e., U.S. treasury securities, U.S. government agency securities, certificates of deposit and corporate debt securities), as well as our assets and liabilities arising from our foreign currency forward contracts and our interest rate swap contracts, are classified within Level II. The fair value of our Level II financial assets and liabilities is determined by using inputs based on non-binding market consensus prices that are primarily corroborated by observable market data or quoted market prices for similar instruments, for substantially the full term of the financial assets and liabilities. Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of July 31, 2024: Level I Level II Level III Fair Value Quoted Prices Significant Significant (in thousands) Cash equivalents: Money market funds $ 956,932 $ 956,932 $ — $ — U.S. treasury securities 178,173 — 178,173 — U.S. government agency securities 57,549 — 57,549 — Certificates of deposit 80,940 — 80,940 — Total cash equivalents $ 1,273,594 $ 956,932 $ 316,662 $ — Short-term investments: U.S. treasury securities $ 257,021 $ — $ 257,021 $ — U.S. government agency securities 160,075 — 160,075 — Corporate debt securities 569,478 — 569,478 — Total short-term investments $ 986,574 $ — $ 986,574 $ — Total cash equivalents and short-term investments $ 2,260,168 $ 956,932 $ 1,303,236 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,541 $ — $ 2,541 $ — Foreign currency contracts assets-noncurrent (2) $ 800 $ — $ 800 $ — Foreign currency contracts liabilities-current (3) $ 3,731 $ — $ 3,731 $ — Foreign currency contracts liabilities-noncurrent (4) $ 844 $ — $ 844 $ — Interest rate contracts liabilities-current (3) $ 3,829 $ — $ 3,829 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,132 $ — $ 2,132 $ — Foreign currency contracts liabilities-current (3) $ 1,748 $ — $ 1,748 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2023: Level I Level II Level III Fair Value Quoted Prices Significant Significant (in thousands) Cash equivalents: Money market funds $ 768,003 $ 768,003 $ — $ — U.S. treasury securities 157,220 — 157,220 — U.S. government agency securities 166,636 — 166,636 — Corporate debt securities 38,800 — 38,800 — Total cash equivalents $ 1,130,659 $ 768,003 $ 362,656 $ — Short-term investments: U.S. treasury securities $ 173,576 $ — $ 173,576 $ — U.S. government agency securities 262,095 — 262,095 — Corporate debt securities 402,355 — 402,355 — Total short-term investments $ 838,026 $ — $ 838,026 $ — Total cash equivalents and short-term investments $ 1,968,685 $ 768,003 $ 1,200,682 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 12,581 $ — $ 12,581 $ — Foreign currency contracts assets-noncurrent (2) $ 2,264 $ — $ 2,264 $ — Foreign currency contracts liabilities-current (3) $ 1,452 $ — $ 1,452 $ — Foreign currency contracts liabilities-noncurrent (4) $ 669 $ — $ 669 $ — Interest rate contracts liabilities-current (3) $ 6,439 $ — $ 6,439 $ — Interest rate contracts liabilities-noncurrent (4) $ 1,588 $ — $ 1,588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,061 $ — $ 2,061 $ — Foreign currency contracts liabilities-current (3) $ 465 $ — $ 465 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. We did not have transfers between levels of the fair value hierarchy of assets measured at fair value during the periods presented. Refer to Note 10, Convertible Senior Notes, for the carrying amount and estimated fair value of our convertible senior notes as of July 31, 2024 and 2023.

Balance sheet Components

Balance sheet Components	12 Months Ended
	Jul. 31, 2024
Property, Plant and Equipment [Abstract]
Balance Sheet Components	Balance Sheet Components Property and Equipment and Purchased Intangible Assets Property and equipment consisted of the following: July 31, Estimated Useful Life 2024 2023 (in thousands) Hosting equipment (1) 4 - 5 years $ 418,775 $ 280,851 Capitalized internal-use software 3 - 5 years 197,769 120,877 Computers and equipment 3 - 5 years 6,741 7,107 Purchased software 3 years 1,102 1,311 Furniture and fixtures 5 years 1,071 1,025 Leasehold improvements Shorter of useful life or lease term 7,974 7,608 Total property and equipment, gross 633,432 418,779 Less: Accumulated depreciation and amortization (250,311) (176,424) Total property and equipment, net $ 383,121 $ 242,355 (1) In August 2023, we extended the useful lives of hosting equipment from four Purchased intangible assets consist of internet protocol (IP) addresses and source codes, which are amortized on a straight-line basis over an estimated useful life of 10 years. As of July 31, 2024, their historical cost and accumulated amortization were $12.4 million and $2.8 million, respectively. As of July 31, 2023, their historical cost and accumulated amortization were $8.6 million and $1.6 million, respectively. Purchased intangible assets are included within other noncurrent assets in the consolidated balance sheets. We recognized depreciation and amortization expense on property and equipment and purchased intangible assets of $66.3 million, $55.8 million and $40.5 million in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Additionally, we recognized stock-based compensation expense on the amortization of capitalized stock-based compensation associated with capitalized internal-use software of $13.0 million , $8.4 million and $4.5 million in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Accrued compensation Accrued compensation consisted of the following: July 31, 2024 2023 (in thousands) Accrued commissions $ 51,371 $ 47,997 Accrued bonuses 53,452 37,417 Accrued payroll and related expenses 47,184 44,024 Employee stock purchase plan 8,803 7,362 Total accrued compensation $ 160,810 $ 136,800

Business Combinations

Business Combinations	12 Months Ended
	Jul. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Business Combinations	Business Combinations Airgap Networks Inc. On April 12, 2024, we completed the acquisition of Airgap Networks Inc. ("Airgap"), an early-stage technology company incorporated in the United States, for total purchase price consideration of $124.4 million. We plan to integrate Airgap's technology into our cloud platform. In addition to the consideration noted above, pursuant to the terms of the purchase agreement, certain Airgap employees who became our employees are entitled to receive deferred merger consideration with a fair value as of the grant date of $20.3 million payable in the form of restricted shares of our common stock. These awards are subject to time-based vesting and will be recognized as stock-based compensation expense during the post-combination period. Additionally, in connection with this acquisition, we committed to issue replacement awards with a fair value as of the closing date of the acquisition of $6.2 million, of which $1.4 million attributable to pre-combination vesting was allocated to the purchase price consideration. The remaining balance is attributable to post-combination vesting and will be recognized as compensation expense during the post-combination period. In connection with this acquisition, we completed a valuation of the acquired identifiable intangible assets as of April 12, 2024. The purchase price consideration was allocated on a preliminary basis, subject to working capital adjustment, to identified intangible assets, which include $28.7 million of developed technology, $3.1 million of customer relationships, and $95.5 million of goodwill. The developed technology was valued using a replacement cost approach, which is based on the cost of a market participant to reconstruct a substitute asset of comparable utility. The customer relationships were also valued using the replacement cost approach, which is based on the cost a market participant would incur to generate the acquired portfolio of customers. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies. The acquisition-related transaction expenses were not material and recorded as incurred within general and administrative expenses in the consolidated statement of operations for fiscal 2024. The acquisition qualified as a stock transaction for tax purposes. The goodwill is not expected to be deductible for income tax purposes. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the fair value of the acquired intangible assets, deferred tax and goodwill. The preliminary allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 5,764 Acquired intangible assets: Developed technology 28,700 5 years Customer relationships 3,100 5 years Goodwill 95,463 Total $ 133,027 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 3,467 Deferred tax liability 5,123 Total $ 8,590 Total purchase price consideration $ 124,437 Avalor Technologies Ltd. On March 8, 2024 we completed the acquisition of Avalor Technologies Ltd. ("Avalor"), an early-stage technology company incorporated in Israel, for total purchase price consideration of $256.7 million. We plan to integrate this company's technology into our cloud platform. In addition to the consideration noted above, pursuant to the terms of the stock purchase agreement, certain Avalor employees who became our employees are entitled to receive deferred merger consideration with a fair value as of the grant date of $46.5 million payable in the form of restricted shares of our common stock. These awards are subject to time-based vesting and will be recognized as stock-based compensation expense during the post-combination period. Additionally, in connection with this acquisition, we committed to issue replacement awards with a fair value as of the closing date of the acquisition of $14.4 million, of which $2.4 million attributable to pre-combination vesting was allocated to the purchase price consideration. The remaining balance is attributable to post-combination vesting and will be recognized as compensation expense during the post-combination period. In connection with this acquisition, we completed a valuation of the acquired identifiable intangible assets as of March 8, 2024. The purchase price consideration was allocated on a preliminary basis, s ubject to working capital adjustment to identified intangible assets, which include $14.7 million of developed technology, $3.3 million of customer relationships, and $229.2 million of goodwill. The developed technology was valued using a replacement cost approach, which is based on the cost of a market participant to reconstruct a substitute asset of comparable utility. The customer relationships were also valued using the replacement cost approach, which is based on the cost a market participant would incur to generate the acquired portfolio of customers. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies. The acquisition-related transaction expenses were not material and recorded as incurred within general and administrative expenses in the consolidated statement of operations for fiscal 2024. The acquisition qualified as a stock transaction for tax purposes. The goodwill is not expected to be deductible for income tax purposes. During the measurement period, which may be up to one year from the acquisition date, we may record adjustments to the fair value of the acquired intangible assets, deferred tax and goodwill. The preliminary allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 13,405 Acquired intangible assets: Developed technology 14,700 5 years Customer relationships 3,300 5 years Deferred tax asset 841 Goodwill 229,151 Total $ 261,397 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 4,017 Deferred tax liability 693 Total $ 4,710 Total purchase price consideration $ 256,687 Securelyshare Software Private Ltd. On August 31, 2023, we completed the acquisition of Securelyshare Software Private Ltd. ("Securelyshare"), an early-stage technology company incorporated in India, for total purchase price consideration of $5.3 million. We have integrated this company's technology into our cloud platform. The transaction was accounted for as a business combination. We recognized intangible assets of $2.8 million for developed technology and goodwill of $3.2 million. The developed technology is amortized over its economic useful life of five years. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies. The acquisition qualified as a stock transaction for tax purposes. The goodwill is not expected to be deductible for income tax purposes. The acquisition-related transaction expenses were not material and recorded as incurred within general and administrative expenses in the consolidated statement of operations for fiscal 2024. Canonic Security Technologies Ltd. On February 20, 2023, we completed the acquisition of Canonic Security Technologies Ltd. ("Canonic"), an early-stage technology company incorporated in Israel, for total purchase price consideration of $16.5 million . We have integrated this company's technology into our cloud platform. In addition to the cash consideration noted above, pursuant to the terms of the purchase agreement, certain of Canonic's employees who became our employees are entitled to receive deferred merger consideration with a fair value as of the grant date of $4.1 million payable in the form of restricted shares of our common stock. These awards are subject to time-based vesting and will be recognized as stock-based compensation expense during the post-combination period. In connection with this acquisition, we completed a valuation of the acquired identifiable assets as of February 20, 2023. The allocation of the purchase price consideration resulted in the recognition of $10.6 million of goodwill and $5.1 million of developed technology. The developed technology was valued using a replacement cost approach, which is based on the cost of a market participant to reconstruct a substitute asset of comparable utility. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies. The acquisition-related transaction expenses were not material and recorded as incurred within general and administrative expenses in the consolidated statement of operations for fiscal 2023. The acquisition qualified as a stock transaction for tax purposes. The goodwill is not expected to be deductible for income tax purposes. The allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 673 Acquired intangible assets: Developed technology 5,100 5 years Deferred tax asset 781 Goodwill 10,645 Total $ 17,199 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 692 Total $ 692 Total purchase price consideration $ 16,507 ShiftRight, Inc. On June 17, 2022, we completed the acquisition of ShiftRight, Inc. (“ShiftRight”), an early-stage technology company incorporated in the United States for a total purchase price consideration of $25.6 million . We have integrated this company’s technology into our cloud platform. In addition to the cash consideration noted above, pursuant to the terms of the purchase agreement, certain of ShiftRight's employees who became our employees are entitled to receive deferred merger consideration with a fair value as of the grant date of $15.2 million payable in the form of restricted shares of our common stock. These awards are subject to time-based vesting and will be recognized as stock-based compensation expense during the post-combination period. In connection with this acquisition, we completed a valuation of the acquired intangible assets as of June 17, 2022. The allocation of the purchase price consideration resulted in the recognition of $18.7 million of goodwill and $7.1 million of developed technology. The developed technology was valued using a replacement cost approach, which is based on the cost of a market participant to reconstruct a substitute asset of comparable utility. Goodwill represents the excess of the purchase price paid over the fair value of the net assets acquired and is primarily attributable to the acquired workforce and expected operating synergies. The acquisition-related transaction expenses were not material and recorded as incurred within general and administrative expenses in the consolidated statement of operations for fiscal 2022. The acquisition qualified as a stock transaction for tax purposes. The goodwill is not expected to be deductible for income tax purposes. The allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash and other assets $ 535 Acquired intangible assets: Developed technology 7,100 5 years Goodwill 18,724 Total $ 26,359 Liabilities assumed: Deferred tax liability $ 682 Other liabilities 99 Total $ 781 Total purchase price consideration $ 25,578 Other Business Combinations In November 2021 , we completed a business acquisition for a total purchase price consideration of $2.1 million, consisting of $0.4 million paid in cash at closing and the issuance of shares of our common stock with an aggregate fair value of $1.7 million at closing. In addition to the cash consideration noted above, pursuant to the terms of the purchase agreement, certain employees of the acquired company who became our employees are entitled to receive deferred merger consideration payable in the form of restricted shares of our common stock. These awards are subject to time-based vesting and will be recognized as stock-based compensation expense during the post-combination period. Based on the valuation of the acquired intangible assets, the allocation of the purchase price consideration resulted in the recognition of $1.6 million of developed technology and $0.8 million of goodwill. The developed technology is amortized over its economic useful life of 5.0 years . The acquisition-related transaction expenses were not material and recorded as incurred within general and administrative expenses in the consolidated statement of operations for fiscal 2022. The acquisition qualified as a stock transaction for tax purposes. Goodwill is not expected to be deductible for income tax purposes. Pro Forma Financial Information

Goodwill and Acquired Intangibl

Goodwill and Acquired Intangible Assets	12 Months Ended
	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Acquired Intangible Assets	Goodwill and Acquired Intangible Assets Goodwill Changes in the carrying amount of goodwill consisted of the following: Amount (in thousands) Balance as of July 31, 2023 $ 89,192 Goodwill acquired 327,837 Balance as of July 31, 2024 $ 417,029 Acquired Intangible Assets Acquired intangible assets consist of developed technology and customer relationships acquired through our business acquisitions and asset acquisitions. Acquired intangible assets are amortized using the straight-line method over their estimated useful lives. During fiscal 2024, in connection with the acquisition of Airgap, Avalor and Securelyshare, we acquired developed technology and customer relationships with a fair value of $46.2 million and $6.4 million, respectively, and each of them with an estimated useful life of five years. For further information refer to Note 6, Business Combinations. Changes in acquired intangible assets for July 31, 2024 and 2023, consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful life July 31, 2023 Additions July 31, 2024 July 31, 2023 Amortization Expense July 31, 2024 July 31, 2023 July 31, 2024 July 31, 2024 (in thousands) (years) Developed technology $ 53,456 $ 46,200 $ 99,656 $ (29,259) $ (13,392) $ (42,651) $ 24,197 $ 57,005 4.2 Customer relationships 3,560 6,400 9,960 (1,898) (1,232) (3,130) 1,662 6,830 4.4 Total $ 57,016 $ 52,600 $ 109,616 $ (31,157) $ (14,624) $ (45,781) $ 25,859 $ 63,835 4.2 As of July 31, 2023, the weighted-average remaining useful life for developed technology and customer relationships was 3.0 years and 2.3 years , respectively. Amortization expense of acquired intangible assets was $14.6 million, $11.1 million and $9.0 million in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Amortization expense of developed technology and customer relationships is included primarily within cost of revenue and sales and marketing expenses, respectively, in the consolidated statements of operations. Future amortization expense of acquired intangible assets as of July 31, 2024 consists of the following: Amount (in thousands) Fiscal Year ending July 31, 2025 $ 16,785 2026 15,772 2027 12,948 2028 11,115 2029 7,215 Total $ 63,835

Derivative Instruments

Derivative Instruments	12 Months Ended
	Jul. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	Derivative Instruments Foreign Currency Forward Contracts As a global business, we are exposed to foreign currency exchange rate risk. Substantially all of our revenue is transacted in U.S. dollars; however, a portion of our cost of revenue and operating expenditures are incurred outside of the United States and are denominated in foreign currencies, making them subject to fluctuations in foreign currency exchange rates. In order to mitigate the impact of foreign currency fluctuations on our future cash flows and earnings, we enter into foreign currency forward contracts, which we designate as cash flow hedges. The maximum length of time over which forecasted foreign currency denominated operating expenses are hedged is 21 months. All cash flow hedges were considered effective for all periods presented. We also use foreign currency forward contracts to mitigate variability in gains and losses generated from the remeasurement of certain monetary assets and liabilities denominated in foreign currencies. The outstanding non-designated derivative instruments are carried at fair value with the change in fair value recorded in other expense, net in the consolidated statement of operations in the same period as the changes in fair value from the remeasurement of the underlying assets and liabilities. Cash flows from such derivatives are classified as operating activities. These foreign exchange contracts typically have maturities of approximately one As of July 31, 2024 and July 31, 2023, the total notional amount of our outstanding designated foreign currency forward contracts was $544.5 million and $457.6 million, respectively, and for our outstanding non-designated foreign currency forward contracts was $352.8 million and $182.9 million, respectively. As of July 31, 2024, an estimated $2.2 million of the unrealized gain related to our cash flow hedges are expected to be released into earnings over the next 12 months. Refer to Note 4, Fair Value Measurements, for the fair value of our derivative instruments as reported on the consolidated balance sheet as of July 31, 2024 and July 31, 2023. Changes in the fair value of our non-designated derivative instruments recognized within other expense, net in the consolidated statement of operations were not material for all periods presented. The changes in accumulated other comprehensive income (loss) related to our cash flow hedges consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Balance of AOCI as of the beginning of the period $ 8,937 $ (13,745) $ (628) Net unrealized gains (losses) recognized in accumulated other comprehensive income (10,761) 11,103 (20,130) Gains (losses) reclassified from AOCI into the consolidated statement of operations (1) (2,400) 11,579 7,013 Balance of AOCI as of the end of the period $ (4,224) $ 8,937 $ (13,745) (1) (Gains) losses related to our cash flow hedges reclassified from AOCI into the consolidated statement of operations consisted of the following : Year Ended July 31, 2024 2023 2022 (in thousands) Cost of revenue $ (785) $ 1,835 $ 617 Sales and marketing (789) 7,670 520 Research and development (433) 1,506 284 General and administrative (393) 568 5,592 Total $ (2,400) $ 11,579 $ 7,013 Our derivative contracts expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the underlying contracts. We mitigate this credit risk by transacting with major financial institutions with high credit ratings and standards. We periodically assess the creditworthiness of our counterparties to ensure they continue to meet our credit quality requirements. We also enter into master netting arrangements, which permit net settlement of transactions with the same counterparty. The potential impact of these rights of set-off associated with our derivative instruments was not material as of July 31, 2024 and July 31, 2023. We are not required to pledge, and are not entitled to receive, cash collateral related to these derivative instruments. We do not enter into derivative contracts for trading or speculative purposes. Interest Rate Swap Contracts During fiscal 2023, we entered into interest rate swaps contracts, maturing on July 1, 2025, designated as fair value hedges intended to hedge a portion of our fair value risk exposure due to changing interest rates by economically converting the fixed interest rate of a certain tranche of our convertible senior notes to a floating interest rate. As of July 31, 2024 and July 31, 2023, the carrying amount of the hedged convertible senior notes was $498.2 million and $496.4 million, respectively. The total notional amount of our outstanding interest rate swaps was $500.0 million as of July 31, 2024 and July 31, 2023. The gains and losses related to changes in the fair value of the interest rate swaps are included within interest expense in the consolidated statement of operations and substantially offset changes in the fair value of the hedged portion of the underlying convertible senior notes that are attributable to the changes in underlying benchmark interest rates. As of July 31, 2024 and July 31, 2023, the cumulative amount of fair value hedge accounting adjustments included in the carrying amount of the convertible senior notes was $4.1 million and $8.3 million, respectively. The effect of derivative instruments designated as fair value hedges included within interest expense in the statement of operations consisted of the following: Gains (Losses) Year Ended July 31, 2024 2023 (in thousands) Interest rate swaps: Hedge accounting fair value adjustments $ (4,241) $ 8,306 Derivatives designated as hedging instruments 4,198 (8,028) Total $ (43) $ 278

Restructuring and Other Charges

Restructuring and Other Charges	12 Months Ended
	Jul. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring and Other Charges	Restructuring and Other Charges On March 1, 2023, we announced a restructuring plan as a part of our planned efforts to streamline operations and to align people, roles, and projects to our strategic priorities. These actions included the reduction of our worldwide headcount by approximately 3%. During fiscal 2023, we incurred $7.6 million of restructuring charges, consisting of $6.6 million of employee severance and benefit charges and $1.0 million of stock-based compensation expense related to modified equity incentive awards. These charges were recorded within restructuring and other charges

Convertible Senior Notes

Convertible Senior Notes	12 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior Notes On June 25, 2020, we issued $1,150.0 million in aggregate principal amount of 0.125% convertible senior notes due 2025 (the "Notes"), including the exercise in full by the initial purchasers of the Notes of their option to purchase an additional $150.0 million principal amount of the Notes. The Notes are unsecured obligations and bear interest at a rate of 0.125% per year and interest is payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2021. The Notes mature on July 1, 2025, unless earlier converted, redeemed or repurchased. The total net proceeds from the offering, after deducting initial purchase discounts and other debt issuance costs, was $1,130.5 million . The Notes do not contain any financial covenants or restrictions on the payments of dividends, the incurrence of indebtedness or the issuance or repurchase of securities by us or any of our subsidiaries. The following table presents details of the Notes: Initial Conversion Rate per $1,000 Principal Initial Conversion Price Initial Number of Shares (in thousands) Notes 6.6315 shares $150.80 7,626 The Notes are convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding April 1, 2025, only under the following circumstances: • During any fiscal quarter commencing after the fiscal quarter ending on October 31, 2020 (and only during such fiscal quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price of the Notes on each applicable trading day; • During the five-business day period after any five consecutive trading day period (the “measurement period”) in which the trading price per $1,000 principal amount of the Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate of the Notes on each such trading day; • If we call any or all of the Notes for redemption, the Notes called for redemption (or, at our election all Notes) may be submitted for conversion at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or • upon the occurrence of specified corporate events as set forth within the indenture governing the Notes. On or after April 1, 2025, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert, all or any portion of their Notes at any time, in multiples of $1,000 principal amount, at their option regardless of the foregoing circumstances. Upon conversion, we will satisfy the conversion obligation by paying or delivering, as the case may be, cash, shares of our common stock or a combination of cash and shares of our common stock, at our election. It is our current intent to settle the principal amount of the Notes in cash. During the three months ended July 31, 2024, the conditions allowing holders of the Notes to convert were not met. As of July 31, 2024, we classified the Notes within current liabilities as they mature on July 1, 2025. As of July 31, 2023, we classified the Notes within noncurrent liabilities as we had the election of repaying the Notes in cash, shares of our common stock, or a combination of both. Conversion notices received were not material for any period presented. Prior to July 5, 2023, we were not permitted to redeem the Notes. On and subsequent to July 5, 2023, and prior to the 21st scheduled trading day immediately preceding the maturity date, we may redeem for cash all or any portion of the Notes, at our option, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day-period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which we provide notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. No sinking fund is provided for the Notes. If we redeem less than all the outstanding Notes, and only Notes called for redemption may be converted in connection with such partial redemption, at least $100.0 million aggregate principal amount of Notes must be outstanding and not subject to such partial redemption as of the relevant redemption notice date. In the event of a corporate event that constitutes a “fundamental change" (as defined in the indenture governing the Notes), holders of the Notes will have the right, at their option to require us to repurchase for cash all or any portion of the Notes upon the occurrence of a fundamental change, at a purchase price equal to 100% of the principal amount of the Notes plus any accrued and unpaid interest, up to but excluding, the date of such repurchase. In addition, following certain corporate events that occur prior to the maturity date, or if we issue a notice of redemption, we will, in certain circumstances, increase the conversion rate for a holder who elects to convert its Notes in connection with such corporate event or notice of redemption, as the case may be. In accounting for the issuance of the Notes and the related transaction costs, we separated the Notes into liability and equity components. The carrying amount of the liability component was initially calculated by measuring the fair value of similar liabilities that do not have associated convertible features utilizing the interest rate of 5.75%. The carrying amount of the equity component representing the conversion option was $278.5 million and was determined by deducting the fair value of the liability component from the par value of the Notes. This difference represents the debt discount that is amortized to interest expense over the term of the Notes using the effective interest rate method. The equity component was recorded in additional paid-in capital and is not remeasured as long as it continues to meet the conditions for equity classification. Total issuance costs of $19.5 million related to the Notes were allocated between liability, totaling $14.8 million, and equity, totaling $4.7 million, in the same proportion as the allocation of the total proceeds to the liability and equity components. Issuance costs attributable to the liability component are being amortized to interest expense over the term of the Notes. The excess of the principal amount of the liability component over its carrying amount is amortized to interest expense over the contractual term of the Notes at an effective interest rate of 6.03%. The issuance costs attributable to the equity component were netted against additional paid-in capital. The amount recorded for the equity component of the Notes was $273.4 million, net of allocated issuance costs of $4.7 million and deferred tax impact of $0.4 million. Upon adoption of ASU 2020-06 as of August 1, 2022, we accounted for our Notes as a single unit of debt and no longer record the conversion feature in equity. This further eliminated the need for amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity is now classified as debt and amortized as interest expense. As of August 1, 2022, the adoption of this new standard resulted in an increase of $169.9 million to the carrying amount of the convertible senior notes, a decrease of $273.7 million to additional paid-in capital and a cumulative-effect adjustment of $103.8 million to accumulated deficit. For further information, refer to Note 1, Business and Summary of Significant Accounting Policies. During fiscal 2023, we entered into interest rate swap contracts designated as fair value hedges of certain of our Notes. For further information refer to Note 8, Derivative Instruments. The net carrying amount of the Notes consisted of the following: July 31, 2024 2023 (in thousands) Principal amount $ 1,149,954 $ 1,149,993 Less: Unamortized debt issuance costs 3,614 7,528 Hedge accounting fair value adjustments 4,065 8,306 Total $ 1,142,275 $ 1,134,159 The interest expense related to the Notes consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Contractual interest expense $ 1,436 $ 1,439 $ 1,438 Amortization of debt discount (1) — — 52,358 Amortization of debt issuance costs (1) 3,914 3,894 2,783 Total $ 5,350 $ 5,333 $ 56,579 (1) The decrease in total interest expense beginning in fiscal 2023, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies. The total fair value of the Notes was $1,465.5 million and $1,411.4 million as of July 31, 2024 and 2023, respectively. The fair value was determined based on the closing trading price per $1,000 of the Notes as of the last day of trading for the period. We consider the fair value of the Notes as of July 31, 2024 and 2023 to be a Level II measurement as they are not actively traded. The fair value of the Notes is primarily affected by the trading price of our common stock and market interest rates. In connection with the pricing of the Notes, we entered into capped call transactions with the option counterparties (the "Capped Calls"). The Capped Calls each have an initial strike price of $150.80 per share, subject to certain adjustments, which corresponds to the initial conversion price of the Notes. The Capped Calls have an initial cap price of $246.76 per share, subject to certain adjustments. The Capped Calls are generally expected to reduce potential dilution to our common stock upon any conversion of the Notes and/or offset any cash payments we are required to make in excess of the principal amount of the converted Notes, as the case may be, with such reduction and/or offset subject to a cap. The Capped Calls are subject to adjustment upon the occurrence of specified extraordinary events affecting us, including merger events, tender offers and the announcement of such events. In addition, the Capped Calls are subject to certain specified additional disruption events that may give rise to a termination of the Capped Calls, including nationalization, insolvency or delisting, changes in law, failures to deliver, insolvency filings and hedging disruptions. For accounting purposes, the Capped Calls are separate transactions, and not part of the terms of the Notes. As the Capped Calls qualify for a scope exception from derivative accounting for instruments that are both indexed to the issuer's own stock and classified in stockholder's equity in the consolidated balance sheet, the premium of $145.2 million paid for the purchase of the Capped Calls was recorded as a reduction to additional paid-in capital and will not be remeasured. We have not exercised any Capped Call options during any of the periods presented.

Operating Leases

Operating Leases	12 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Operating Leases	Operating Leases The following is a summary of our operating lease costs: Year Ended July 31, 2024 2023 2022 Real Estate Arrangements Co-Location Arrangements Total Real Estate Arrangements Co-Location Arrangements Total Real Estate Arrangements Co-Location Arrangements Total (in thousands) Operating lease, including imputed interest $ 9,902 $ 39,577 $ 49,479 $ 7,858 $ 24,677 $ 32,535 $ 6,347 $ 19,356 $ 25,703 Short-term lease cost 5,138 8,090 13,228 4,314 5,688 10,002 2,826 1,889 4,715 Variable lease cost 9,907 6,047 15,954 6,992 4,956 11,948 3,163 4,480 7,643 Total operating lease costs $ 24,947 $ 53,714 $ 78,661 $ 19,164 $ 35,321 $ 54,485 $ 12,336 $ 25,725 $ 38,061 Weighted-average remaining lease term (in years) 2.1 1.9 3.0 2.0 3.7 2.7 Weighted-average discount rate 5.3 % 4.7 % 4.5 % 3.2 % 4.1 % 2.2 % The following table presents information about our leases in the consolidated balance sheets: July 31, 2024 2023 Real Estate Arrangements Co-Location Arrangements Total Real Estate Arrangements Co-Location Arrangements Total (in thousands) Operating lease right-of-use assets $ 22,612 $ 67,146 $ 89,758 $ 18,493 $ 52,178 $ 70,671 Operating lease liabilities, current $ 11,381 $ 39,485 $ 50,866 $ 6,777 $ 27,692 $ 34,469 Operating lease liabilities, noncurrent $ 12,974 $ 31,850 $ 44,824 $ 14,875 $ 27,042 $ 41,917 Cash paid, net of tenant incentives for amounts included in the measurement of operating lease liabilities was $49.2 million, $32.2 million and $27.7 million for fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Maturities of operating lease liabilities consisted of the following as of July 31, 2024: Real Estate Arrangements Co-Location Arrangements Total Year ending July 31, (in thousands) 2025 $ 12,381 $ 41,920 $ 54,301 2026 10,537 24,396 34,933 2027 2,481 8,598 11,079 2028 481 — 481 Total future minimum lease payments 25,880 74,914 100,794 Less: Imputed interest 1,525 3,579 5,104 Total $ 24,355 $ 71,335 $ 95,690 As of July 31, 2024, we have entered into non-cancelable operating leases with a term greater than 12 months that have not yet commenced with undiscounted future minimum payments of $9.6 million , which are excluded from the above table. These operating leases will commence between August 2024 and November 2024 with lease terms of approximately 3.0 years.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Non-cancelable Purchase Obligations In the normal course of business, we enter into non-cancelable purchase commitments with various third parties to purchase products and services such as cloud infrastructure capacity, subscription-based cloud service arrangements, technology equipment, corporate and marketing events and consulting services. The maturities of non-cancelable purchase obligations with a remaining term in excess of one year as of July 31, 2024 consisted of the following: Amount Year ending July 31, (in thousands) 2025 $ 57,961 2026 77,644 2027 51,088 2028 38,967 2029 18,750 Total $ 244,410 Other Commitments As of July 31, 2024 and 2023 , we had outstanding irrevocable standby unsecured letters of credits and a guarantee for an aggregate value of $2.5 million and $2.1 million, respectively which serve as security under certain real estate leases included in Note 11, Operating Leases. Legal Matters Litigation and Claims We are a party to various litigation matters from time to time and subject to claims that arise in the ordinary course of business, including patent, commercial, product liability, employment, class action, whistleblower and other litigation and claims, as well as governmental and other regulatory investigations and proceedings. In addition, third parties may from time to time assert claims against us in the form of letters and other communications. There is no pending or threatened legal proceeding to which we are a party that, in our opinion, is likely to have a material adverse effect on our future financial results or operations; however, the results of litigation and claims are inherently unpredictable. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors. The expense of litigation and the timing of this expense from period to period are difficult to estimate, subject to change and could adversely affect our results of operations.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation Equity Incentive Plan Equity incentive awards which may be granted to eligible participants under our Fiscal Year 2018 Equity Incentive Plan (the "2018 Plan") include restricted stock units, restricted stock, stock options, nonstatutory stock options, stock appreciation rights, performance units and performance shares. As of July 31, 2024, a total of 53.1 million shares of common stock have been reserved for the issuance of equity awards under the 2018 Plan, of which 30.9 million shares were available for grant. The number of shares of common stock available for issuance under the 2018 Plan also includes an annual increase on the first day of each fiscal year pursuant to its automatic annual increase provision. Stock Options The activity of stock options for fiscal 2024 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2023 1,267 $18.54 2.1 $ 179,678 Granted 50 $198.03 Exercised (864) $14.17 $ 157,832 Canceled, forfeited or expired — — Balance as of July 31, 2024 453 $46.72 2.5 $ 60,923 Exercisable and expected to vest as of July 31, 2023 1,210 $12.82 1.8 $ 178,616 Exercisable and expected to vest as of July 31, 2024 367 $15.84 1.0 $ 59,989 The weighted-average grant-date fair value per share of stock options granted was $117.41 and $88.97 during fiscal 2024 and fiscal 2023 respectively. There were no stock options granted during fiscal 2022 . The total grant-date fair value of stock options vested was $1.4 million, $1.5 million and $3.9 million during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The total intrinsic value of options exercised was $157.8 million, $56.5 million and $230.1 million, during fiscal 2024, fiscal 2023 and fiscal 2022, respectively . We estimate the fair value of stock options using the Black-Scholes option pricing model with the following assumptions: Year Ended July 31 2024 2023 Expected term (in years) 6.0 6.1 Expected stock price volatility 59.5% 58.2% Risk-free interest rate 4.2% 3.9% Dividend yield 0.0% 0.0% The expected term was estimated using the simplified method. The expected volatility was determined using a weighted-average of the historical volatility of our common stock and peer volatility. Peer volatility was calculated as the average of historical volatilities of selected industry peers corresponding to the expected term of the awards. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the stock-based award. Our expected dividend yield is zero, as we have not and do not currently intend to declare dividends in the foreseeable future. Restricted Stock Units and Performance Stock Awards The 2018 Plan allows for the grant of RSUs and PSAs. Generally, RSUs are subject to a four-year vesting period. The right to earn PSAs is subject to the achievement of the defined and approved performance metrics and continuous employment service. The performance metrics are defined and approved by the compensation committee of our board of directors or by our senior management for certain types of awards. Generally, earned PSAs are subject to additional time-based vesting. As of July 31, 2024, outstanding PSAs for which their performance metrics have not been defined and/or approved were not material. As of July 31, 2024, these awards are not considered granted for accounting purposes and accordingly, have been excluded from the table below . The activity of RSUs and PSAs consisted of the following for fiscal 2024: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2023 9,351 $139.95 $ 1,499,714 Granted 6,018 $181.24 Vested (3,624) $136.82 $ 684,393 Canceled or forfeited (1,931) $160.35 Balance as of July 31, 2024 9,814 $162.41 $ 1,760,079 The aggregate fair value, as of the respective vesting dates, of RSUs and PSAs vested was $684.4 million, $462.3 million and $694.9 million, during fiscal 2024, fiscal 2023 and fiscal 2022, respectively. Employee Stock Purchase Plan In fiscal 2018, we adopted the Fiscal Year 2018 Employee Stock Purchase Plan (the "ESPP"). Through July 31, 2024, a total of 10.3 million shares of common stock have been reserved for issuance under the ESPP, out of which 6.3 million shares were available for future grant as of July 31, 2024. The number of shares reserved includes an annual increase on the first day of each fiscal year pursuant to the ESPP's automatic annual increase provision. The ESPP provides for consecutive offering periods that will typically have a duration of approximately 24 months in length and are comprised of four purchase periods of approximately six months in length. The offering periods are scheduled to start on the first trading day on or after June 15 and December 15 of each year. The ESPP contains a reset provision under which the offering period resets if the fair market value of our common stock on the purchase date is less than the fair market value on the first day of the offering period. During fiscal 2024, fiscal 2023 and fiscal 2022, employees purchased under the ESPP approximately 0.5 million, 0.4 million and 0.3 million shares of common stock, respectively, at an average purchase price of $106.46, $99.59 and $108.61, respectively, with cash proceeds of $52.0 million, $42.3 million and $34.6 million, respectively. ESPP employee payroll contributions accrued as of July 31, 2024 and 2023, were $8.8 million and $7.4 million, respectively, and are included within accrued compensation in the consolidated balance sheets. Payroll contributions accrued as of July 31, 2024 will be used to purchase shares at the end of the current ESPP purchase period ending on December 16, 2024. Payroll contributions ultimately used to purchase shares are reclassified to stockholders' equity on the purchase date. In June 2024, one outstanding ESPP offering period was reset and automatically rolled over into a new ESPP offering period that started on June 17, 2024. The reset was accounted for as a modification, which resulted in an incremental stock-based compensation of $2.7 million, which will be recognized over the remaining term of the modified ESPP offering period of 18 months. In December 2022, certain outstanding ESPP offering periods were reset and automatically rolled over into a new ESPP offering period that started on December 15, 2022. The reset was accounted for as a modification, which resulted in an incremental stock-based compensation of $8.3 million, which has been recognized over the remaining term of the modified ESPP offering periods, ranging from approximately 6 months to 18 months. The fair value of the purchase rights offered under the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended July 31, 2024 2023 2022 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected stock price volatility 42.5% - 64.8% 58.1% - 75.9% 44.1% - 79.4% Risk-free interest rate 4.4% - 5.4% 4.2% - 5.3% 0.1% - 3.2% Dividend yield 0.0% 0.0% 0.0% The expected term represents the term from the first day of the offering period to the purchase dates within each offering period. The expected volatility was based on the historical volatility of our common stock. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the stock-based award. Our expected dividend yield is zero, as we have not and do not currently intend to declare dividends in the foreseeable future. Departure of the Chief Operating Officer of the Company In February 2024, our Chief Operating Officer, who led sales activities, resigned from his position at the Company. In connection with his resignation, we recognized a reversal of stock-based compensation expense of $11.7 million associated with the cancellation of unvested incentive equity awards, which was recognized in sales and marketing expenses in the consolidated statement of operations in fiscal 2024. Departure of the President of the Company In October 2022, our President, who led research and development activities, resigned from his position as President of the Company, but continued to serve as a member of our Board of Directors through January 2024. In connection with his resignation as President of the Company, we recognized a reversal of stock-based compensation expense of $9.9 million associated with the cancellation of unvested incentive equity awards, which was recognized in research and development expenses in the consolidated statement of operations in fiscal 2023. Modification of Equity Incentive Awards During fiscal 2023, we modified the equity incentive awards of certain employees. In accordance with the accounting for the modification, we recognized stock-based compensation expense of $6.0 million in research and development expenses and $1.3 million in sales and marketing expenses, respectively, in the consolidated statement of operations in fiscal 2023. The stock-based compensation expense from modified equity incentive awards in fiscal 2024 and fiscal 2022 was not material. Stock-based Compensation Expense The components of stock-based compensation expense recognized in the consolidated statements of operations consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Cost of revenue $ 50,820 $ 39,168 $ 23,847 Sales and marketing 219,096 215,597 191,091 Research and development 180,554 117,915 118,299 General and administrative 77,206 71,118 76,325 Restructuring and other charges — 1,036 — Total $ 527,676 $ 444,834 $ 409,562 As of July 31, 2024, the unrecognized stock-based compensation cost related to outstanding equity-based awards, including awards for which the service inception date has been met but the grant date has not been met, was $1,519.8 million, which we expect to be amortized over a weighted-average period of 2.8 years. During fiscal 2024, fiscal 2023 and fiscal 2022, we capitalized stock-based compensation primarily associated with the development of software for internal-use of $27.2 million, $17.2 million and $11.5 million, respectively.

Common Stock

Common Stock	12 Months Ended
	Jul. 31, 2024
Equity [Abstract]
Common Stock	Common Stock Holders of our common stock are entitled to one vote for each share of common stock held and are not entitled to receive dividends unless declared by our board of directors. Common Stock Reserved for Future Issuance The following table summarizes our shares of common stock reserved for future issuance: July 31, 2024 (in thousands) Equity awards outstanding: Stock options 453 Unvested RSUs 8,805 Committed unvested PSAs, based on the target number of shares 607 Unvested PSAs 1,009 Share purchase rights committed under the ESPP 514 Equity awards available for future grants: 2018 Plan 30,892 ESPP 6,255 Stock reserved for settlement of the Notes 7,626 Total 56,161

Income Taxes

Income Taxes	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The following table sets forth the geographical breakdown of the income (loss) before the provision for income taxes: Year ended July 31, 2024 2023 2022 (in thousands) Domestic $ (112,758) $ (228,715) $ (413,148) International 83,529 46,151 29,518 Loss before provision for income taxes $ (29,229) $ (182,564) $ (383,630) The following table sets forth the components of the provision for income taxes: Year ended July 31, 2024 2023 2022 Current: (in thousands) Federal $ 203 $ 1,091 $ — State 1,337 3,890 399 Foreign 32,620 14,438 6,996 Total current tax expense 34,160 19,419 7,395 Deferred: Federal (4,526) — (858) State (693) — (185) Foreign (464) 352 296 Total deferred tax benefit (expense) (5,683) 352 (747) Total provision for income taxes $ 28,477 $ 19,771 $ 6,648 During fiscal 2024, fiscal 2023 and fiscal 2022, we recognized tax benefits on total stock-based compensation expense of $23.0 million, $13.4 million and $1.4 million, respectively, which are reflected within the provision for income taxes in the consolidated statements of operations. The following table presents the reconciliation of the statutory federal income tax rate to our effective rate: Year ended July 31, 2024 2023 2022 Tax at federal statutory rate 21.0 % 21.0 % 21.0 % State taxes (0.4) (2.1) (0.1) Impact of foreign rate differential 36.2 10.1 (0.4) Stock-based compensation 162.6 (0.8) 17.6 U.S. tax credits 101.8 8.6 3.9 Change in valuation allowance (471.3) (34.1) (43.6) Withholding tax (12.5) (1.3) (0.2) Waived deductions under Section 59A 74.3 (11.8) — Transaction costs (1.3) — — Meals and entertainment (7.0) (0.8) (0.2) Other (0.8) 0.3 0.3 Effective tax rate (97.4) % (10.9) % (1.7) % Our effective tax rate for fiscal 2024 differs from the U.S. statutory rate primarily due to a portion of our earnings that are taxed at different rates from the U.S. statutory rate, the benefit of stock compensation deductions, withholding taxes related to customer payments in certain foreign jurisdictions in which we conduct business, and the impact of the valuation allowance we maintain against our U.S. federal and state deferred tax assets. During fiscal 2024, we also effectuated certain tax planning actions which reduced the amount of waived deductions under Section 59A related to our fiscal 2023. Our effective tax rate for fiscal 2023 differs from the U.S. statutory rate primarily due to a portion of our earnings that are taxed at different rates from the U.S. statutory rate, the effect of waived deductions under Section 59A, the benefit of stock compensation deductions, withholding taxes related to customer payments in certain foreign jurisdictions in which we conduct business, and the impact of the valuation allowance we maintain against our U.S. federal and state deferred tax assets. Our effective tax rate for fiscal 2022 differs from the U.S. statutory rate primarily due to our foreign earnings that are taxed at different rates than the U.S. statutory rate, the benefit of stock compensation deductions, withholding taxes related to customer payments in certain foreign jurisdictions in which we conduct business, and the impact of the valuation allowance we maintain against our U.S. federal and state deferred tax assets. During fiscal 2024 and 2022, we recognized an income tax benefit of $5.2 million and $1.0 million, respectively, as a result of a release in our valuation allowance on deferred tax assets due to deferred taxes recorded as part of the acquisition accounting of business combinations . During fiscal 2023 , we did not recognize income tax benefits from business combinations. Refer to Note 6, Business Combinations, for further information. The following table presents the tax effects of temporary differences that give rise to significant portions of our deferred tax assets and liabilities: July 31, 2024 2023 (in thousands) Deferred tax assets: Net operating losses carryovers $ 373,611 $ 401,261 Deferred revenue 181,654 122,326 Research and development capitalization 168,918 92,901 Tax credits carryovers 157,861 98,564 Other 100,930 75,641 Gross deferred tax assets 982,974 790,693 Less: Valuation allowance (833,908) (671,381) Total deferred tax assets $ 149,066 $ 119,312 Deferred tax liabilities: Intangible assets $ (10,273) $ (4,765) Deferred contract acquisition costs (99,123) (86,805) Property and equipment (9,929) (4,690) Operating lease right-of-use assets (29,137) (22,403) Total deferred tax liabilities $ (148,462) $ (118,663) Net deferred tax assets $ 604 $ 649 A deferred tax liability has not been recognized on the excess of the amount for financial reporting over the tax basis of investments in foreign subsidiaries that are indefinitely reinvested outside the U.S. Income taxes are generally incurred upon a repatriation of assets, a sale, or a liquidation of the subsidiary. The excess of the amount for financial reporting over the tax basis in the investments in foreign subsidiaries, as well as the unrecognized deferred tax liability, are not material for the periods presented. The following table presents the change in the valuation allowance: Year ended July 31, 2024 2023 2022 (in thousands) Balance as of the beginning of the period $ 671,381 $ 553,916 $ 345,756 Change during the period 162,527 117,465 208,160 Balance as of the end of the period $ 833,908 $ 671,381 $ 553,916 The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. We regularly assess our ability to realize the deferred tax assets on a quarterly basis and we establish a valuation allowance if it is more-likely-than-not that some portion of the deferred tax assets will not be realized. We weigh all available positive and negative evidence, including our earnings history and results of recent operations, scheduled reversals of deferred tax liabilities, projected future taxable income, and tax planning strategies. Due to the weight of objectively verifiable negative evidence, including our history of losses, we believe that it is more likely than not that our U.S. federal and state deferred tax assets will not be realized as of July 31, 2024 and 2023. Accordingly, we have maintained a full valuation allowance against such deferred tax asset s. Due to the weight of objectively verifiable negative evidence, our U.K. deferred tax assets are not more likely than not to be realized in the future and a full valuation allowance has been maintained as of July 31, 2024 and 2023. The amount of the deferred tax asset considered realizable, however, could be adjusted if estimates of future taxable income during the carryforward period are reduced or increased or if objective negative evidence in the form of cumulative losses is no longer present and additional weight may be given to subjective evidence such as our projections for growth. In the event we determine that we will be able to realize all or part of our net deferred tax assets in the future, the valuation allowance against our deferred tax assets will be reversed in the period in which we make such determination. The release of a valuation allowance may cause greater volatility in the effective tax rate in the periods in which the valuation allowance is released. The valuation allowance against our U.S. federal, state and U.K. deferred tax assets increased by $162.5 million, $117.5 million and $208.2 million in fiscal 2024, fiscal 2023 and fiscal 2022, respectively. The increase in the valuation allowance in fiscal 2024 , fiscal 2023 and fiscal 2022 was related to tax losses for which insufficient positive evidence exists to support their realizability. As of July 31, 2024, we have net operating loss carryforwards for U.S. federal income tax purposes of $1,497.6 million, which are available to offset future federal taxable income. These net operating losses will carry forward indefinitely. As of July 31, 2024, we have net operating loss carryforwards for state income tax purposes of $630.8 million. Beginning in 2024, $554.9 million of state net operating losses will begin to expire at different periods. The remaining $75.9 million of state net operating losses will carry forward indefinitely. As of July 31, 2024, we had foreign net operating loss carryforward of $75.6 million, all of which will be carried forward indefinitely. As of July 31, 2024, we also had U.S. federal, California and foreign research and development and other tax credit carryforwards of $133.4 million, $73.9 million and $1.9 million respectively. If not utilized, the federal research and development tax credit carryforwards will begin expiring at different periods beginning in 2033. Our California research and development tax credits may be carried forward indefinitely. Foreign tax credits will begin to expire in the fiscal year ending 2029. Federal and state tax laws impose restrictions on the utilization of net operating loss carryforwards in the event of a change in our ownership as defined by the Internal Revenue Code, Sections 382. Under Section 382 of the Code, substantial changes in our ownership and the ownership of acquired companies may limit the amount of net operating loss carryforwards that are available to offset taxable income. The annual limitation would not automatically result in the loss of net operating loss carryforwards but may limit the amount available in any given future period. We are subject to income taxes in the U.S. and various foreign jurisdictions. As of July 31, 2024, all years are open for examination and may become subject to examination in the future. Significant judgment is required in evaluating our tax positions and determining our income tax expense for the fiscal year. During the ordinary course of business, there are transactions and calculations for which the ultimate tax determination is uncertain. Our estimate of the potential outcome of any tax position is subject to management’s assessment of relevant risks, facts and circumstances existing at that time. These unrecognized tax benefits are established when we believe that certain positions might be challenged despite the belief that our tax return positions are fully supportable. We recognize interest and penalties associated with our unrecognized tax benefits as a component of our income tax expense. For the periods presented, we did not have material interest or penalties associated with the unrecognized tax benefits in the consolidated financial statements. We had $63.9 million of gross unrecognized tax benefits as of July 31, 2024, of which $2.9 million would affect our effective tax rate if recognized. The remaining gross unrecognized tax benefits relate to income tax positions which, if recognized, would be in the form of additional deferred tax assets that would be offset by a valuation allowance. As of July 31, 2024, we do not believe that our estimates, as otherwise provided for, on such tax positions will significantly increase or decrease within the next twelve months. We recognize interest and penalties related to our unrecognized tax benefits within our provision for income taxes. The amount of interest and penalties accrued as of July 31, 2024 were insignificant. The changes in our gross unrecognized tax benefits consisted of the following: Amount (in thousands) Balance as of July 31, 2022 $ 29,699 Gross increase for tax positions of prior years 1,653 Gross (decrease) for tax positions of prior years — Gross increase for tax positions of current year 9,337 Balance as of July 31, 2023 40,689 Gross increase for tax positions of prior years 6,960 Gross (decrease) for tax positions of prior years (2,102) Gross increase for tax positions of current year 18,378 Balance as of July 31, 2024 $ 63,925

Net Loss Per Share

Net Loss Per Share	12 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. The diluted net loss per share is computed by giving effect to all potential dilutive common stock equivalents outstanding for the period. For purposes of this calculation, our stock options, share purchase rights under the employee stock purchase plan, unvested RSUs, unvested PSAs, unvested common stock and shares related to the Notes are considered to be potential common stock equivalents. The computation of basic and diluted net loss per share consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands, except per share data) Net loss $ (57,706) $ (202,335) $ (390,278) Weighted-average shares used in computing net loss per share, basic and diluted 149,586 144,942 140,895 Net loss per share, basic and diluted $ (0.39) $ (1.40) $ (2.77) Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share as their effect is antidilutive and accordingly, the basic and diluted net loss per share is the same for all periods presented. Prior to the adoption of ASU 2020-06, we calculated the potential dilutive effect of the Notes under the treasury stock method. As a result, only the amount by which the conversion value exceeded the aggregate principal amount of the Notes (the “conversion spread”) was considered in the diluted earnings per share computation. The conversion spread only had a dilutive impact on diluted net income per share when the average market price of our common stock for a given reporting period exceeded the initial conversion price of $150.80 per share for the Notes. Upon the adoption of ASU 2020-06 on August 1, 2022, we calculated the potential dilutive effect of the Notes under the if-converted method. Under this method, diluted earnings per share are determined by assuming that all of the Notes were converted into shares of our common stock at the beginning of the reporting period. In connection with the issuance of the Notes, we entered into Capped Calls, which were not included for purposes of calculating the number of diluted shares outstanding, as their effect would have been anti-dilutive. The Capped Calls are expected to partially offset the potential dilution to our common stock upon any conversion of the Notes. We have not exercised any of the Capped Calls as of July 31, 2024. The following table summarizes the outstanding potentially dilutive securities that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: July 31, 2024 2023 2022 (in thousands) Unvested RSUs and shares of common stock 9,198 8,442 6,769 Stock options 453 1,267 1,673 Unvested PSAs (1) 1,009 1,012 832 Share purchase rights under the ESPP 514 1,119 850 Notes (2) 7,626 7,626 7,626 Total 18,800 19,466 17,750 (1) The number of unvested PSAs is estimated at 100% of the target number of shares granted and excludes unvested PSAs for which performance conditions have not been established as of July 31, 2024, as they are not considered outstanding for accounting purposes. For further information refer to Note 13, Stock-Based Compensation. (2) The shares underlying the conversion option in the Notes were not considered in the calculation of diluted net loss per share for all the periods presented, as their effect would have been antidilutive. Based on the initial conversion price, the entire outstanding principal amount of the Notes as of July 31, 2024 would have been convertible into approximately 7.6 million shares of our common stock, which is reflected in the above table. As we expect to settle the principal amount of the Notes in cash, only the amount by which the conversion value exceeds the aggregate principal amount of the Notes (the "conversion spread") is considered in the diluted earnings per share computation under the treasury stock method. The conversion spread has a dilutive impact on diluted net income per share when the average market price of our common stock for a given reporting period exceeds the initial conversion price of $150.80

Segment and Geographic Informat

Segment and Geographic Information	12 Months Ended
	Jul. 31, 2024
Risks and Uncertainties [Abstract]
Segment and Geographic Information	Segment and Geographic Information Our chief operating decision maker ("CODM") is our chief executive officer. We derive our revenue primarily from sales of subscription services to our cloud platform and related support services. Our CODM reviews financial information presented on a consolidated basis for the purposes of allocating resources and evaluating financial performance. Accordingly, we determined that we operate as one operating segment. Our long-lived assets consist of property and equipment and operating lease right-of-use assets, which are summarized by geographic area as follows: July 31, 2024 2023 (in thousands) United States $ 325,146 $ 213,611 Rest of the world 147,735 99,415 Total $ 472,881 $ 313,026 Refer to Note 2, Revenue Recognition for information on revenue by geography.

401(k) Plan

401(k) Plan	12 Months Ended
	Jul. 31, 2024
Retirement Benefits [Abstract]
401(k) Plan	401(k) Plan We have a defined-contribution plan intended to qualify under Section 401 of the Internal Revenue Code (the "401(k) Plan"). We contract with a third-party provider to act as a custodian and trustee, and to process and maintain the records of participant data. We make matching contributions to the plan for our employees. Our matching contributions to the plan were not material for all the periods presented.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ (57,706)	$ (202,335)	$ (390,278)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	12 Months Ended
	Jul. 31, 2024 shares	Jul. 31, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Robert Schlossman [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		Securities Trading Plans of Directors and Executive Officers During our last fiscal quarter, the following officers and directors, as defined in Rule 16a-1(f), adopted a “Rule 10b5-1 trading arrangement” as defined in Regulation S-K Item 408, as follows: On June 29, 2024, Robert Schlossman, the Company’s chief legal officer and secretary, adopted a Rule 10b5-1 trading arrangement providing for the sale from time to time of an aggregate of (i) up to 24,793 shares of our common stock and (ii) up to 100% of the shares of our common stock issued upon the settlement of 30,987 outstanding RSUs and PSUs, less the number of shares sold to cover tax withholding obligations in connection with the vesting and settlement of such RSUs and PSUs. The trading arrangement is intended to satisfy the affirmative defense in Rule 10b5-1(c). The duration of the trading arrangement is until September 25, 2025, or earlier if all transactions under the trading arrangement are completed.
Name	Robert Schlossman
Title	chief legal officer and secretary
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 29, 2024
Expiration Date	September 25, 2025
Arrangement Duration	453 days
Aggregate Available	24,793	24,793

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Jul. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Business and Summary of Signi_2

Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jul. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Fiscal Year	Fiscal Year Our fiscal year ends on July 31. References to fiscal 2024, for example, refer to our fiscal year ending July 31, 2024.
Principles of Consolidation	Principles of Consolidation
Use of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Such estimates include, but are not limited to, the determination of revenue recognition, deferred revenue, deferred contract acquisition costs, capitalized internal-use software, valuation of acquired intangible assets, period of benefit generated from our deferred contract acquisition costs, allowance for doubtful accounts, valuation of common stock options and stock-based awards, useful lives of property and equipment, useful lives of acquired intangible assets, recoverability of goodwill, valuation of deferred tax assets and liabilities, loss contingencies related to litigation, fair value of convertible senior notes and the discount rate used for operating leases. Management determines these estimates and assumptions based on historical experience and on various other assumptions that are believed to be reasonable. Actual results could differ significantly from these estimates, and such differences may be material to the consolidated financial statements. Due to uncertainty in the macroeconomic environment, including the effects of inflation and geopolitical events, there is ongoing disruption in the global economy and financial markets. We are not aware of any specific event or circumstances that would require an update to our estimates, judgments or assumptions or a revision to the carrying value of our assets or liabilities as of the date of issuance of these consolidated financial statements. These estimates, judgments and assumptions may change in the future, as new events occur or additional information is obtained.
Foreign Currency	Foreign Currency The functional currency of our foreign subsidiaries is the U.S. dollar. Accordingly, monetary assets and liabilities of our foreign subsidiaries are re-measured into U.S. dollars at the exchange rates in effect at the reporting date, non-monetary assets and liabilities are re-measured at historical rates, revenue and expenses are re-measured at average exchange rates in effect during each reporting period. Foreign currency transaction gains and losses are recorded in other expense, net in the consolidated statements of operations. Foreign currency remeasurement gains and losses and foreign currency transaction gains and losses are not significant to the consolidated financial statements for all periods presented.
Concentration of Risks	Concentration of Risks We generate revenue primarily from sale of subscriptions to access our cloud platform, together with related support services. Our sales team, along with our channel partner network of global telecommunications service providers, system integrators and value-added resellers (collectively "channel partners"), sells our services worldwide to organizations of all sizes. Due to the nature of our services and the terms and conditions of our contracts with our channel partners, our business could be affected unfavorably if we are not able to continue our relationships with them. Our financial instruments that are exposed to concentrations of credit risk consist primarily of cash, cash equivalents, derivative contracts, short-term investments and accounts receivable. Although we deposit our cash with multiple financial institutions, the deposits, at times, may exceed federally insured limits. Cash equivalents and short-term investments consist of highly liquid investments in money market funds, U.S. treasury, U.S. agency securities, certificates of deposit and corporate debt securities, which are invested through financial institutions. We grant credit to our customers in the normal course of business. We monitor the financial condition of our customers to reduce credit risk. Refer to Note 2, Revenue Recognition, for information regarding customers with concentration of 10% or more of the total balance of accounts receivable, net.
Segment Information	Segment Information We operate as one reportable and operating segment. Our chief operating decision maker is our chief executive officer, who reviews financial information presented on a consolidated basis for purposes of making operating decisions, assessing financial performance and allocating resources.
Revenue Recognition	Revenue Recognition In accordance with Accounting Standards Codification ("ASC") Topic 606, Revenue From Contracts With Customers ("ASC 606"), revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration that we expect to be entitled to receive in exchange for these services. To achieve the core principle of this standard, we apply the following five steps: 1) Identify the contract with a customer We consider the terms and conditions of the contracts and our customary business practices in identifying our contracts under ASC 606. We determine we have a contract with a customer when the contract is approved, we can identify each party’s rights regarding the services to be transferred, we can identify the payment terms for the services, we have determined the customer has the ability and intent to pay and the contract has commercial substance. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information pertaining to the customer. 2) Identify the performance obligations in the contract Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. Our performance obligations consist of (i) our subscription and support services and (ii) professional and other services. 3) Determine the transaction price The transaction price is determined based on the consideration to which we expect to be entitled in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in our judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of our contracts contain a significant financing component. 4) Allocate the transaction price to performance obligations in the contract If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price ("SSP"). 5) Recognize revenue when or as we satisfy a performance obligation Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised service to a customer. Revenue is recognized when control of the services is transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those services. We generate all our revenue from contracts with customers and apply judgment in identifying and evaluating any terms and conditions in contracts which may impact revenue recognition. Subscription and Support Revenue We generate revenue primarily from sales of subscriptions to access our cloud platform, together with related support services to our customers. Arrangements with customers do not provide the customer with the right to take possession of our software operating our cloud platform at any time. Instead, customers are granted continuous access to our cloud platform over the contractual period. A time-elapsed output method is used to measure progress because we transfer control evenly over the contractual period. Accordingly, the fixed consideration related to subscription and support revenue is generally recognized on a straight-line basis over the contract term beginning on the date that our service is made available to the customer. The typical subscription and support term is one Professional and Other Services Revenue Professional and other services revenue consists of fees associated with providing deployment advisory services that educate and assist our customers on the best use of our solutions, as well as advise customers on best practices as they deploy our solution. These services are distinct from subscription and support services. Professional services do not result in significant customization of the subscription service. Revenue from professional services provided on a time and materials basis is recognized as the services are performed. Total professional and other services revenue has historically not been material. Contracts with Multiple Performance Obligations Most of our contracts with customers contain multiple promised services consisting of: (i) our subscription and support services and (ii) professional and other services that are distinct and accounted for separately. The transaction price is allocated to the separate performance obligations on a relative SSP basis. We determine SSP based on our overall pricing objectives, taking into consideration the type of subscription and support services and professional and other services, the geographical region of the customer and the number of users. Variable Consideration Revenue from sales is recorded at the net sales price, which is the transaction price, and includes estimates of variable consideration. The amount of variable consideration that is included in the transaction price is constrained and included in the net sales price only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue will not occur when the uncertainty is resolved. If our services do not meet certain service level commitments, our customers are entitled to receive service credits, and in certain cases, refunds, each representing a form of variable consideration. We have historically not experienced any significant incidents affecting the defined levels of reliability and performance as required by our subscription contracts. Accordingly, estimated refunds related to these agreements were not material to the periods presented. We provide rebates and other credits within our contracts with certain customers, which are estimated based on the value expected to be earned or claimed on the related sales transaction. Overall, the transaction price is reduced to reflect our estimate of the amount of consideration to which we are entitled based on the terms of the contract. Estimated rebates and other credits were not material during the periods presented.
Accounts Receivable and Allowance	Accounts Receivable and Allowance Accounts receivable are recorded at the invoiced amount and are non-interest bearing. Accounts receivable are stated at their net realizable value, net of an allowance for doubtful accounts. We have a well-established collections history from our customers. Credit is extended to customers based on an evaluation of their financial condition and other factors. In determining the necessary allowance for doubtful accounts, we estimate the lifetime expected credit losses against the existing accounts receivable balance. Our estimate is based on certain factors including historical loss rates, current economic conditions, reasonable and supportable forecasts and customer-specific circumstances. The allowance for doubtful accounts has historically not been material. There were no material write-offs recognized in the periods presented. Accordingly, the movements in the allowance for doubtful accounts were not material for any of the periods presented. We do not have any off-balance-sheet credit exposure related to our customers.
Cash Equivalents	We classify all highly liquid investments purchased with an original maturity of 90 days or less from the date of purchase as cash equivalents and all highly liquid investments with original maturities beyond 90 days at the time of purchase as short-term investments. Our cash equivalents and short-term investments consist of highly liquid investments in money market funds, U.S. treasury securities, U.S. government agency securities, certificates of deposit and corporate debt securities.
Short-Term Investments	We classify our investments as available-for-sale investments and present them within current assets since these investments represent funds available for current operations and we have the ability and intent, if necessary, to liquidate any of these investments in order to meet our liquidity needs or to grow our business, including for potential business acquisitions or other strategic transactions. Our investments are carried at fair value, with unrealized gains and losses unrelated to credit loss factors reported in accumulated other comprehensive income (loss) ("AOCI"). Our investments are reviewed periodically when there is a decline in a security’s fair value below the amortized cost basis. We consider our intent to sell and whether it is more likely than not that we will be required to sell the securities before the recovery of its cost basis. If either of these criteria are triggered, the amortized cost basis of the debt security is written down to fair value through other expense, net. If neither criteria is met, we evaluate whether the decline in fair value below the amortized cost basis is related to credit-related factors or other factors such as interest rate fluctuations. The factors considered in this analysis include the extent the fair value is less than the amortized cost basis, whether there were changes to the rating of the security by a ratings agency, whether the issuer has failed to make scheduled interest payments and other adverse conditions as applicable. Credit-related impairment losses, limited by the amount that the fair value is less than the amortized cost basis, are recorded through an allowance for credit losses in other expense, net. For purposes of identifying and measuring credit-related impairments, our policy is to exclude the applicable accrued interest from both the fair value and amortized cost basis of the related debt security. Accrued interest receivable, net of the allowance for credit losses, if any, is recorded to prepaid expenses and other current assets. There were no credit-related impairments recognized on our investments during the periods presented. Interest income, amortization (accretion) of investments purchased at a premium (discount) and realized gains and losses are included in interest income in the consolidated statements of operations. We use the specific identification method to determine the cost in calculating realized gains and losses upon the sale of these investments.
Strategic Investments	Strategic Investments Our strategic investments consist of non-marketable equity investments of privately held companies. Investments in non-marketable equity investments of privately held companies without readily determinable fair values are measured using the measurement alternative, as we have less than 20% ownership and do not have the ability to exercise significant influence over their operations. The carrying amount of non-marketable equity investments is adjusted based on observable price changes from orderly transactions for identical or similar investments of the same issuer and by impairments when events or circumstances indicate a decline in value has occurred. Non-marketable equity investments that have been remeasured during the period due to an observable event or impairment are classified within Level 3 in the fair value hierarchy because we estimate the value based on valuation methods which may include a combination of the observable transaction price at the transaction date and other unobservable inputs including volatility, rights, and obligations of the investments we hold. Our strategic investments are included within other noncurrent assets in the consolidated balance sheets and adjustments to their carrying amounts are recorded in other expense, net in the consolidated statements of operations. There were no material events or circumstances impacting the carrying amount of our strategic investments during the periods presented.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Our financial instruments consist of cash equivalents, short-term investments, accounts receivable, accounts payable, accrued liabilities, derivative instruments and convertible senior notes. Cash e quivalents and short-term investments are recorded at fair value. Accounts receivable, accounts payable and accrued liabilities are stated at their carrying value, which approximates fair value due to the short-time to the expected receipt or payment date. Assets recorded at fair value on a recurring basis in the consolidated balance sheets, consisting of cash equivalents and short-term investments, are categorized in accordance with the fair value hierarchy based upon the level of judgment associated with the inputs used to measure their fair values. We carry the convertible senior notes at face value less debt issuance costs and hedge accounting fair value adjustments on our consolidated balance sheet. The fair value of the convertible senior notes is presented at each reporting period for disclosure purposes only.
Property and Equipment	Property and Equipment Property and equipment, net are stated at historical cost net of accumulated depreciation. Property and equipment, excluding leasehold improvements, are depreciated using the straight-line method over the estimated useful lives of the three
Capitalized Internal-Use Software	Capitalized Internal-Use Software three
Business Combinations	Business Combinations We account for our business combinations using the acquisition method of accounting, which requires, among other things, allocation of the fair value of purchase consideration to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, we make estimates and assumptions, especially with respect to intangible assets. Our estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period, not to exceed one year from the date of acquisition, we may record adjustments to the assets acquired and liabilities assumed, with a corresponding offset to goodwill if new information is obtained related to facts and circumstances that existed as of the acquisition date. After the measurement period, any subsequent adjustments are reflected in the consolidated statements of operations. Acquisition costs, such as legal and consulting fees, are expensed as incurred.
Goodwill and Intangible Assets	Goodwill represents the excess of the fair value of purchase consideration in a business combination over the fair value of net tangible and intangible assets acquired. Goodwill amounts are not amortized, but rather tested for impairment at least annually or more often if circumstances indicate that the carrying value may not be recoverable. There was no impairment of goodwill during any of the periods presented. Acquired intangible assets consist of identifiable intangible assets, including developed technology and customer relationships, resulting from business combinations. Acquired finite-lived intangible assets are initially recorded at fair value and are amortized on a straight-line basis over their estimated useful lives. Amortization expense of developed technology and customer relationships is recorded primarily within cost of revenues and sales and marketing expenses, respectively, in the consolidated statements of operations.
Impairment of Long-Lived Assets	Long-lived assets, such as property and equipment and acquired intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that their carrying amounts may not be recoverable. We measure the recoverability of these assets by comparing the carrying amounts to the future undiscounted cash flows that these assets are expected to generate. If the total of the future undiscounted cash flows are less than the carrying amount of an asset, we record an impairment charge for the amount by which the carrying amount of the asset exceeds the fair value.
Restructuring and Other Charges	Restructuring and Other Charges Restructuring and other charges occur when we commit to a restructuring plan, the restructuring plan identifies all significant actions, the period of time to complete the restructuring plan indicates that significant changes to the restructuring plan are not likely and employees who are impacted have been notified of the pending involuntary termination. A restructuring plan generally includes significant actions involving employee-related severance charges, employee-related benefits, stock-based compensation expense related to the modification of equity incentive awards and other charges associated with the restructuring (the "restructuring charges"). Restructuring charges are accrued in the period in which it is probable that the employees are entitled to the restructuring benefits and the amounts can be reasonably estimated. Restructuring charges are recorded within restructuring and other charges in the consolidated statement of operations. The restructuring liability accrued but not paid at the end of the reporting period is included within accrued compensation in the consolidated balance sheets.
Derivative Instruments	Derivative Instruments We enter into foreign currency forward contracts, a portion of which we designate as cash flow hedges, in order to manage the volatility of cash flows that relate to our cost of revenues and operating expenses denominated in foreign currencies. We also use interest rate swaps to economically convert a certain tranche of our fixed interest rate convertible senior notes to floating interest rates, in order to match the floating rate nature of a portion of our cash, cash equivalents, and short-term investments. These interest rate swaps are designated as fair value hedges, and changes in fair value of the interest rate swaps offset the changes in fair market value of the convertible senior notes due to benchmark interest rate movements. Gains or losses related to our fair value hedges are included within interest expense in the consolidated statement of operations in the period of change together with the offsetting loss or gain on the hedged item attributed to the risk being hedged. We measure hedge effectiveness of the interest rate swaps using regression analysis at inception and periodically thereafter. Gains or losses related to our cash flow hedges are recorded as a component of AOCI in the consolidated statements of stockholders' equity until the forecasted transaction occurs in earnings. When the forecasted transaction occurs, the related gains and losses are reclassified into earnings within the financial statement line item associated with the underlying hedged transaction. If the underlying hedged transaction does not occur, or it becomes probable that the hedged transaction will not occur, the cumulative unrealized gain or loss is reclassified immediately from AOCI into earnings within the financial statement line item associated with the underlying hedged transaction. We measure hedge effectiveness using regression analysis at hedge inception and periodically thereafter. We include time value in our effectiveness assessment. We recognize changes in the fair value of non-designated derivative instruments within other expense, net in the consolidated statements of operations in the same period that the fair value measurement occurs. All of our derivative instruments are measured at fair value. We have elected to present the derivative assets and derivative liabilities on a gross basis on the consolidated balance sheets. Derivative instruments are classified in the consolidated statements of cash flows as cash from operating activities, which reflect the classification of the underlying hedged transactions.
Operating Leases	Operating Leases We enter into operating lease arrangements for real estate assets related to office space and co-location assets related to space and racks at data center facilities. We determine if an arrangement contains a lease at its inception by assessing whether there is an identified asset and whether the arrangement conveys the right to control the use of the identified asset in exchange for consideration. Operating leases related balances are included in "operating lease right-of-use assets," "operating lease liabilities," and "operating lease liabilities, noncurrent" in the consolidated balance sheets. Right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make payments arising from the lease. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease payments consist of the fixed payments under the arrangement. The operating lease liabilities are adjusted for any unpaid lease incentives, such as tenant improvement allowances. Variable costs, such as maintenance and utilities based on actual usage, are not included in the measurement of right-to-use assets and lease liabilities but are expensed when the event determining the amount of variable consideration to be paid occurs. As the implicit rate of our leases is not determinable, we use an incremental borrowing rate ("IBR") based on the information available at the lease commencement date in determining the present value of lease payments. The lease expense is recognized on a straight-line basis over the lease term. We generally use the base, non-cancelable lease term when recognizing the right-of-use assets and lease liabilities, unless it is reasonably certain that a renewal or termination option will be exercised. We account for lease components and non-lease components as a single lease component. Leases with a term of twelve months or less are not recognized on the consolidated balance sheets.
Stock-Based Compensation	Stock-Based Compensation Compensation expense related to stock-based awards granted to employees and non-employees is calculated based on the fair value of stock-based awards on the date of grant. We recognize stock-based compensation expense in the consolidated statement of operations over an award’s requisite service period based on the award’s fair value. Stock-based compensation for common stock options is measured based on the fair value of the awards granted, determined using the Black-Scholes option pricing model. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period, generally four years. Stock-based compensation for purchase rights granted under the employee stock purchase plan ("ESPP") is measured based on the fair value of the number of awards estimated at the beginning of the offering period, as determined using the Black-Scholes option pricing model. Stock-based compensation expense is recognized on a straight-line basis over the two-year offering period. Stock-based compensation for restricted stock units ("RSUs") with only service conditions is measured based on the market closing price of our common stock on the grant date. Stock-based compensation expense is recognized on a straight-line basis over the requisite service period, generally four years. Stock-based compensation for performance stock awards (“PSAs”), which have the same grant date and service inception date, and subject to both service and performance conditions, is measured based on the probable number of shares to be attained and the market closing price of our common stock at the grant date. The expense is recognized using the accelerated attribution method over the requisite service period. For PSAs where the service inception date of the awards precedes the grant date, stock-based compensation expense is recognized based on the number of PSAs for which it is probable that the performance condition will be met, using the accelerated attribution method and the market closing price of our common stock at each reporting date up to the grant date. The number of these PSAs for which it is probable that the performance condition will be met is determined using management’s best estimate at the end of each reporting period. At the completion of the performance period for these PSAs, any earned PSAs are granted upon approval of the compensation committee of our board of directors. We account for forfeitures as they occur for all stock-based awards.
Convertible Senior Notes	Convertible Senior Notes We adopted Financial Accounting Standard Board ("FASB") issued Accounting Standard Update ("ASU") No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity’s Own Equity (Subtopic 815-40) ("ASU 2020-06") as of August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. Prior to the adoption of ASU 2020-06, in accounting for the issuance of the convertible senior notes, the convertible senior notes were separated into liability and equity components. The carrying amounts of the liability component was calculated by measuring the fair value of similar liabilities that do not have associated convertible features. The carrying amount of the equity component representing the conversion option was determined by deducting the fair value of the liability component from the par value of the convertible senior notes as a whole. This difference represents the debt discount that was amortized to interest expense over the respective terms of the convertible senior notes using the effective interest rate method. The equity component was recorded in additional paid-in capital and was not remeasured as long as it continued to meet the conditions for equity classification. In accounting for the related debt issuance costs, we allocated the total amount incurred to the liability and equity components of the convertible senior notes based on their relative values. Issuance costs attributable to the liability component were being amortized to interest expense over the contractual term of the convertible senior notes. The issuance costs attributable to the equity component were netted against the equity component representing the conversion option in additional paid-in capital. To the extent that we receive the convertible senior notes conversion requests prior to their maturity, a portion of the equity component is classified as temporary equity, which is measured as the difference between the principal and net carrying amount of the convertible senior notes requested for conversion. Upon settlement of the conversion requests, the difference between the fair value and the amortized book value of the liability component of the convertible senior notes requested for conversion is recorded as a gain or loss on early note conversion. The fair value of the convertible senior notes is measured based on a similar liability that does not have an associated convertible feature based on the remaining term of the convertible senior notes. Upon adoption of ASU 2020-06 and using the modified retrospective method, prior period amounts have not been adjusted. This standard resulted in our convertible senior notes being accounted for as a single unit of debt and we will no longer be required to record the conversion feature in equity. This further eliminated the need for amortization of the debt discount as interest expense and the portion of the issuance costs initially allocated to equity is now classified as debt and amortized as interest expense. As of August 1, 2022, the adoption of this new standard resulted in an increase of $169.9 million to the carrying amount of the convertible senior notes, a decrease of $273.7 million to additional paid-in capital and a cumulative-effect adjustment of $103.8 million to accumulated deficit. Prior to the adoption of this standard, we used the treasury stock method to calculate the potentially diluted effect of the convertible senior notes; however, upon adoption of this standard we are required to use the if-converted method. Accordingly, to account for the potentially diluted shares related to the convertible senior notes under a net income position, we are required to add back the related interest expense to the net income and include approximately 7.63 million shares related to the convertible senior notes. Since we have reported net losses for all periods presented, the convertible senior
Research and Development	Research and Development Our research and development expenses support our efforts to add new products, new features to our existing offerings and to ensure the reliability, availability and scalability of our solutions. Our cloud platform is software-driven, and our research and development teams employ software engineers in the design and the related development, testing, certification and support of our solutions. Accordingly, the majority of our research and development expenses result from employee-related costs, including salaries, bonuses, benefits, stock-based compensation and costs associated with technology tools used by our engineers.
Advertising Expenses	Advertising Expenses
Warranties and Indemnification	Warranties and Indemnification Our cloud platform is generally warranted to be free of defects under normal use and to perform substantially in accordance with the subscription agreement. Additionally, our contracts generally include provisions for indemnifying customers and channel partners against liabilities if our services infringe or misappropriate a third party’s intellectual property rights. Costs and liabilities incurred as a result of warranties and indemnification obligations were not material during the periods presented.
Legal Contingencies	Legal Contingencies We may be subject to legal proceedings and litigation arising from time to time. We record a liability when we believe that it is both probable that a loss has been incurred and the amount can be reasonably estimated. We periodically evaluate developments in our legal matters that could affect the amount of liability that we accrue, if any, and adjust, as appropriate. Until the final resolution of any such matter for which we may be required to record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. We expense legal fees as incurred.
Income Taxes	I ncome Taxes We account for income taxes using the asset and liability method. Deferred income taxes are recognized by applying the enacted statutory tax rates applicable to future years to differences between the carrying amounts of existing assets and liabilities and their respective tax bases and net operating loss and tax credit carryforwards. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the period that includes the enactment date. The measurement of deferred tax assets is reduced, if necessary, by a valuation allowance to amounts that are more likely than not to be realized. We recognize tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained on examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized upon settlement.
Comprehensive Loss	Comprehensive Loss Comprehensive loss is comprised of the net loss and other comprehensive income (loss). Our other comprehensive income (loss) includes unrealized gains and losses on available-for-sale securities and unrealized gains and losses and realized gains and losses reclassified into net loss on cash flow hedges, as reflected in the consolidated statements of comprehensive loss.
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period, less shares subject to repurchase. D iluted earnings per share adjusts basic earnings per share for all potentially dilutive common stock equivalents outstanding during the period. Potentially dilutive securities consist primarily of stock options, share purchase rights under the ESPP, unvested RSUs, unvested PSAs, unvested common stock and shares related to convertible senior notes. Since we have reported net losses for all periods presented, we have excluded all potentially dilutive securities from the calculation of the diluted net loss per share, as their effect is antidilutive. Accordingly, basic and diluted net loss per share is the same for all periods presented.
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncements In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805) on Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This standard requires contract assets and contract liabilities from contracts with customers that are acquired in a business combination to be recognized and measured as if the acquirer had originated the original contract. Previously, acquired contract assets and liabilities were measured at fair value. We early adopted this standard in the first quarter of fiscal 2022 and it did not have a material impact to the consolidated financial statements. In June 2020, the FASB issued ASU No. 2020-06. This standard removes the separation model for convertible debt with a cash conversion feature and convertible instruments with a beneficial conversion feature. Such convertible debt will be accounted for as a single liability measured at its amortized cost, as long as no other features require bifurcation and recognition as derivatives. The update also requires the if-converted method to be used for convertible instruments and the effect of potential share settlement be included in the diluted earnings per share calculation when an instrument may be settled in cash or shares. We adopted this standard effective on August 1, 2022, the beginning of fiscal 2023, using the modified retrospective method. In accordance with the adoption of ASU 2020-06 and using the modified retrospective method, prior period amounts have not been adjusted. For further information, refer to Convertible Senior Notes section in this Note 1, Business and Summary of Significant Accounting Policies. Recently Issued Accounting Pronouncements Not Yet Adopted In November 2023, the Financial Accounting Standards Board ("FASB") issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures , which requires disclosure of incremental segment information on an annual and interim basis. This standard is effective for us in the annual periods beginning in fiscal 2025 and interim periods beginning in the first quarter of fiscal 2026. We are currently evaluating the potential impact of this standard on financial statement disclosures. In December 2023, the FASB issued 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amended guidance enhances income tax disclosures primarily related to the effective tax rate reconciliation and income taxes paid information. This guidance requires disclosures of specific categories in the effective tax rate reconciliation and further information on reconciling items meeting a quantitative threshold. In addition, the amended guidance requires disaggregating income taxes paid (net of refunds received) by federal, state and foreign taxes. It also requires disaggregating individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received). This standard is effective for us in the annual periods beginning in fiscal 2026 and interim periods beginning in the first quarter of fiscal 2027. We are currently evaluating the potential impact of this standard on financial statement disclosures.

Revenue Recognition (Tables)

Revenue Recognition (Tables)	12 Months Ended
	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table summarizes the revenue by region based on the shipping address of customers who have contracted to use our cloud platform: Year Ended July 31, 2024 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) United States $ 1,092,304 50 % $ 808,527 50 % $ 536,924 49 % Europe, Middle East and Africa 672,421 31 515,136 32 370,035 34 Asia Pacific 327,816 15 241,250 15 155,460 14 Other 75,230 4 52,039 3 28,527 3 Total $ 2,167,771 100 % $ 1,616,952 100 % $ 1,090,946 100 % ____ The following table summarizes the revenue from contracts by type of customer: Year Ended July 31, 2024 2023 2022 Amount % Revenue Amount % Revenue Amount % Revenue (in thousands, except for percentage data) Channel partners $ 1,967,908 91 % $ 1,488,379 92 % $ 1,016,747 93 % Direct customers 199,863 9 128,573 8 74,199 7 Total $ 2,167,771 100 % $ 1,616,952 100 % $ 1,090,946 100 %
Schedule of Capitalized Contract Cost	The activity of the deferred contract acquisition costs consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Beginning balance $ 375,234 $ 297,002 $ 207,030 Capitalization of contract acquisition costs 200,303 176,950 158,503 Amortization of deferred contract acquisition costs (130,139) (98,718) (68,531) Ending balance $ 445,398 $ 375,234 $ 297,002 The outstanding balance of the deferred contract acquisition costs consisted of the following: July 31, 2024 2023 (in thousands) Deferred contract acquisition costs, current $ 148,873 $ 115,827 Deferred contract acquisition costs, noncurrent 296,525 259,407 Total deferred contract acquisition costs $ 445,398 $ 375,234

Cash Equivalents and Short-Te_2

Cash Equivalents and Short-Term Investments (Tables)	12 Months Ended
	Jul. 31, 2024
Cash and Cash Equivalents [Abstract]
Schedule of Cash Equivalents and Short-Term Investments	Cash equivalents and short-term investments consisted of the following as of July 31, 2024: Amortized Unrealized Unrealized Fair Value (in thousands) Cash equivalents: Money market funds $ 956,932 $ — $ — $ 956,932 U.S. treasury securities 178,188 — (15) 178,173 U.S. government agency securities 57,555 — (6) 57,549 Certificates of deposit 80,940 — — 80,940 Total cash equivalents $ 1,273,615 $ — $ (21) $ 1,273,594 Short-term investments: U.S. treasury securities $ 257,841 $ 8 $ (828) $ 257,021 U.S. government agency securities 160,574 43 (542) 160,075 Corporate debt securities 568,589 1,514 (625) 569,478 Total short-term investments $ 987,004 $ 1,565 $ (1,995) $ 986,574 Total cash equivalents and short-term investments $ 2,260,619 $ 1,565 $ (2,016) $ 2,260,168 Cash equivalents and short-term investments consisted of the following as of July 31, 2023: Amortized Unrealized Unrealized Fair Value (in thousands) Cash equivalents: Money market funds $ 768,003 $ — $ — $ 768,003 U.S. treasury securities 157,250 — (30) 157,220 U.S. government agency securities 166,671 — (35) 166,636 Corporate debt securities 38,800 — — 38,800 Total cash equivalents $ 1,130,724 $ — $ (65) $ 1,130,659 Short-term investments: U.S. treasury securities $ 175,451 $ — $ (1,875) $ 173,576 U.S. government agency securities 266,392 2 (4,299) 262,095 Corporate debt securities 406,517 49 (4,211) 402,355 Total short-term investments $ 848,360 $ 51 $ (10,385) $ 838,026 Total cash equivalents and short-term investments $ 1,979,084 $ 51 $ (10,450) $ 1,968,685
Schedule of Maturities	The amortized cost and fair value of our short-term investments based on their stated maturities consisted of the following as of July 31, 2024: Amortized Fair Value (in thousands) Due within one year $ 476,116 $ 475,325 Due between one to three years 510,888 511,249 Total $ 987,004 $ 986,574
Schedule of Unrealized Loss on Investments	Short-term investments that were in continuous unrealized loss position as of July 31, 2024 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 152,574 $ (115) $ 87,808 $ (713) $ 240,382 $ (828) U.S. government agency securities 65,563 (28) 65,334 (514) 130,897 (542) Corporate debt securities 81,020 (102) 94,666 (523) 175,686 (625) Total $ 299,157 $ (245) $ 247,808 $ (1,750) $ 546,965 $ (1,995) Short-term investments that were in continuous unrealized loss position as of July 31, 2023 consisted of the following: Less than 12 Months Greater than 12 Months Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) U.S. treasury securities $ 173,576 $ (1,875) $ — $ — $ 173,576 $ (1,875) U.S. government agency securities 119,558 (292) 131,530 (4,007) 251,088 (4,299) Corporate debt securities 232,504 (2,034) 82,599 (2,177) 315,103 (4,211) Total $ 525,638 $ (4,201) $ 214,129 $ (6,184) $ 739,767 $ (10,385)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of July 31, 2024: Level I Level II Level III Fair Value Quoted Prices Significant Significant (in thousands) Cash equivalents: Money market funds $ 956,932 $ 956,932 $ — $ — U.S. treasury securities 178,173 — 178,173 — U.S. government agency securities 57,549 — 57,549 — Certificates of deposit 80,940 — 80,940 — Total cash equivalents $ 1,273,594 $ 956,932 $ 316,662 $ — Short-term investments: U.S. treasury securities $ 257,021 $ — $ 257,021 $ — U.S. government agency securities 160,075 — 160,075 — Corporate debt securities 569,478 — 569,478 — Total short-term investments $ 986,574 $ — $ 986,574 $ — Total cash equivalents and short-term investments $ 2,260,168 $ 956,932 $ 1,303,236 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,541 $ — $ 2,541 $ — Foreign currency contracts assets-noncurrent (2) $ 800 $ — $ 800 $ — Foreign currency contracts liabilities-current (3) $ 3,731 $ — $ 3,731 $ — Foreign currency contracts liabilities-noncurrent (4) $ 844 $ — $ 844 $ — Interest rate contracts liabilities-current (3) $ 3,829 $ — $ 3,829 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,132 $ — $ 2,132 $ — Foreign currency contracts liabilities-current (3) $ 1,748 $ — $ 1,748 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2023: Level I Level II Level III Fair Value Quoted Prices Significant Significant (in thousands) Cash equivalents: Money market funds $ 768,003 $ 768,003 $ — $ — U.S. treasury securities 157,220 — 157,220 — U.S. government agency securities 166,636 — 166,636 — Corporate debt securities 38,800 — 38,800 — Total cash equivalents $ 1,130,659 $ 768,003 $ 362,656 $ — Short-term investments: U.S. treasury securities $ 173,576 $ — $ 173,576 $ — U.S. government agency securities 262,095 — 262,095 — Corporate debt securities 402,355 — 402,355 — Total short-term investments $ 838,026 $ — $ 838,026 $ — Total cash equivalents and short-term investments $ 1,968,685 $ 768,003 $ 1,200,682 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 12,581 $ — $ 12,581 $ — Foreign currency contracts assets-noncurrent (2) $ 2,264 $ — $ 2,264 $ — Foreign currency contracts liabilities-current (3) $ 1,452 $ — $ 1,452 $ — Foreign currency contracts liabilities-noncurrent (4) $ 669 $ — $ 669 $ — Interest rate contracts liabilities-current (3) $ 6,439 $ — $ 6,439 $ — Interest rate contracts liabilities-noncurrent (4) $ 1,588 $ — $ 1,588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,061 $ — $ 2,061 $ — Foreign currency contracts liabilities-current (3) $ 465 $ — $ 465 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4)
Schedule of Fair Value, Liabilities Measured on Recurring Basis	Assets and liabilities that are measured at fair value on a recurring basis consisted of the following as of July 31, 2024: Level I Level II Level III Fair Value Quoted Prices Significant Significant (in thousands) Cash equivalents: Money market funds $ 956,932 $ 956,932 $ — $ — U.S. treasury securities 178,173 — 178,173 — U.S. government agency securities 57,549 — 57,549 — Certificates of deposit 80,940 — 80,940 — Total cash equivalents $ 1,273,594 $ 956,932 $ 316,662 $ — Short-term investments: U.S. treasury securities $ 257,021 $ — $ 257,021 $ — U.S. government agency securities 160,075 — 160,075 — Corporate debt securities 569,478 — 569,478 — Total short-term investments $ 986,574 $ — $ 986,574 $ — Total cash equivalents and short-term investments $ 2,260,168 $ 956,932 $ 1,303,236 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,541 $ — $ 2,541 $ — Foreign currency contracts assets-noncurrent (2) $ 800 $ — $ 800 $ — Foreign currency contracts liabilities-current (3) $ 3,731 $ — $ 3,731 $ — Foreign currency contracts liabilities-noncurrent (4) $ 844 $ — $ 844 $ — Interest rate contracts liabilities-current (3) $ 3,829 $ — $ 3,829 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,132 $ — $ 2,132 $ — Foreign currency contracts liabilities-current (3) $ 1,748 $ — $ 1,748 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4) Included within other noncurrent liabilities in the consolidated balance sheets. Assets that are measured at fair value on a recurring basis consisted of the following as of July 31, 2023: Level I Level II Level III Fair Value Quoted Prices Significant Significant (in thousands) Cash equivalents: Money market funds $ 768,003 $ 768,003 $ — $ — U.S. treasury securities 157,220 — 157,220 — U.S. government agency securities 166,636 — 166,636 — Corporate debt securities 38,800 — 38,800 — Total cash equivalents $ 1,130,659 $ 768,003 $ 362,656 $ — Short-term investments: U.S. treasury securities $ 173,576 $ — $ 173,576 $ — U.S. government agency securities 262,095 — 262,095 — Corporate debt securities 402,355 — 402,355 — Total short-term investments $ 838,026 $ — $ 838,026 $ — Total cash equivalents and short-term investments $ 1,968,685 $ 768,003 $ 1,200,682 $ — Designated derivative instruments: Foreign currency contracts assets-current (1) $ 12,581 $ — $ 12,581 $ — Foreign currency contracts assets-noncurrent (2) $ 2,264 $ — $ 2,264 $ — Foreign currency contracts liabilities-current (3) $ 1,452 $ — $ 1,452 $ — Foreign currency contracts liabilities-noncurrent (4) $ 669 $ — $ 669 $ — Interest rate contracts liabilities-current (3) $ 6,439 $ — $ 6,439 $ — Interest rate contracts liabilities-noncurrent (4) $ 1,588 $ — $ 1,588 $ — Non-designated derivative instruments: Foreign currency contracts assets-current (1) $ 2,061 $ — $ 2,061 $ — Foreign currency contracts liabilities-current (3) $ 465 $ — $ 465 $ — (1) Included within prepaid expenses and other current assets in the consolidated balance sheets. (2) Included within other noncurrent assets in the consolidated balance sheets. (3) Included within accrued expenses and other current liabilities in the consolidated balance sheets. (4)

Balance Sheet Components (Table

Balance Sheet Components (Tables)	12 Months Ended
	Jul. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following: July 31, Estimated Useful Life 2024 2023 (in thousands) Hosting equipment (1) 4 - 5 years $ 418,775 $ 280,851 Capitalized internal-use software 3 - 5 years 197,769 120,877 Computers and equipment 3 - 5 years 6,741 7,107 Purchased software 3 years 1,102 1,311 Furniture and fixtures 5 years 1,071 1,025 Leasehold improvements Shorter of useful life or lease term 7,974 7,608 Total property and equipment, gross 633,432 418,779 Less: Accumulated depreciation and amortization (250,311) (176,424) Total property and equipment, net $ 383,121 $ 242,355 (1) In August 2023, we extended the useful lives of hosting equipment from four
Schedule of Accrued Compensation	Accrued compensation consisted of the following: July 31, 2024 2023 (in thousands) Accrued commissions $ 51,371 $ 47,997 Accrued bonuses 53,452 37,417 Accrued payroll and related expenses 47,184 44,024 Employee stock purchase plan 8,803 7,362 Total accrued compensation $ 160,810 $ 136,800

Business Combinations (Tables)

Business Combinations (Tables)	12 Months Ended
	Jul. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Net Assets Acquired	The preliminary allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 5,764 Acquired intangible assets: Developed technology 28,700 5 years Customer relationships 3,100 5 years Goodwill 95,463 Total $ 133,027 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 3,467 Deferred tax liability 5,123 Total $ 8,590 Total purchase price consideration $ 124,437 The preliminary allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 13,405 Acquired intangible assets: Developed technology 14,700 5 years Customer relationships 3,300 5 years Deferred tax asset 841 Goodwill 229,151 Total $ 261,397 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 4,017 Deferred tax liability 693 Total $ 4,710 Total purchase price consideration $ 256,687 The allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash, cash equivalents and other assets $ 673 Acquired intangible assets: Developed technology 5,100 5 years Deferred tax asset 781 Goodwill 10,645 Total $ 17,199 Liabilities assumed: Accounts payable, accrued expenses and other liabilities $ 692 Total $ 692 Total purchase price consideration $ 16,507 The allocation of the purchase price consideration consisted of the following: Amount Estimated Useful Life (in thousands) Assets acquired: Cash and other assets $ 535 Acquired intangible assets: Developed technology 7,100 5 years Goodwill 18,724 Total $ 26,359 Liabilities assumed: Deferred tax liability $ 682 Other liabilities 99 Total $ 781 Total purchase price consideration $ 25,578

Goodwill and Acquired Intangi_2

Goodwill and Acquired Intangible Assets (Tables)	12 Months Ended
	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Changes in the carrying amount of goodwill consisted of the following: Amount (in thousands) Balance as of July 31, 2023 $ 89,192 Goodwill acquired 327,837 Balance as of July 31, 2024 $ 417,029
Schedule of Acquired Intangible Assets	Changes in acquired intangible assets for July 31, 2024 and 2023, consisted of the following: Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful life July 31, 2023 Additions July 31, 2024 July 31, 2023 Amortization Expense July 31, 2024 July 31, 2023 July 31, 2024 July 31, 2024 (in thousands) (years) Developed technology $ 53,456 $ 46,200 $ 99,656 $ (29,259) $ (13,392) $ (42,651) $ 24,197 $ 57,005 4.2 Customer relationships 3,560 6,400 9,960 (1,898) (1,232) (3,130) 1,662 6,830 4.4 Total $ 57,016 $ 52,600 $ 109,616 $ (31,157) $ (14,624) $ (45,781) $ 25,859 $ 63,835 4.2
Schedule of Future Amortization Expense	Future amortization expense of acquired intangible assets as of July 31, 2024 consists of the following: Amount (in thousands) Fiscal Year ending July 31, 2025 $ 16,785 2026 15,772 2027 12,948 2028 11,115 2029 7,215 Total $ 63,835

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
	Jul. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Changes of AOCI Related to our Cash Flow Hedges and Cash Flow Hedges on our Consolidated Statement of Operations	The changes in accumulated other comprehensive income (loss) related to our cash flow hedges consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Balance of AOCI as of the beginning of the period $ 8,937 $ (13,745) $ (628) Net unrealized gains (losses) recognized in accumulated other comprehensive income (10,761) 11,103 (20,130) Gains (losses) reclassified from AOCI into the consolidated statement of operations (1) (2,400) 11,579 7,013 Balance of AOCI as of the end of the period $ (4,224) $ 8,937 $ (13,745) (1) (Gains) losses related to our cash flow hedges reclassified from AOCI into the consolidated statement of operations consisted of the following : Year Ended July 31, 2024 2023 2022 (in thousands) Cost of revenue $ (785) $ 1,835 $ 617 Sales and marketing (789) 7,670 520 Research and development (433) 1,506 284 General and administrative (393) 568 5,592 Total $ (2,400) $ 11,579 $ 7,013
Schedule of Derivative Instruments Designated as Fair Value Hedges	The effect of derivative instruments designated as fair value hedges included within interest expense in the statement of operations consisted of the following: Gains (Losses) Year Ended July 31, 2024 2023 (in thousands) Interest rate swaps: Hedge accounting fair value adjustments $ (4,241) $ 8,306 Derivatives designated as hedging instruments 4,198 (8,028) Total $ (43) $ 278

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	12 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
Schedule of Convertible Senior Notes	The following table presents details of the Notes: Initial Conversion Rate per $1,000 Principal Initial Conversion Price Initial Number of Shares (in thousands) Notes 6.6315 shares $150.80 7,626 The net carrying amount of the Notes consisted of the following: July 31, 2024 2023 (in thousands) Principal amount $ 1,149,954 $ 1,149,993 Less: Unamortized debt issuance costs 3,614 7,528 Hedge accounting fair value adjustments 4,065 8,306 Total $ 1,142,275 $ 1,134,159 The interest expense related to the Notes consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Contractual interest expense $ 1,436 $ 1,439 $ 1,438 Amortization of debt discount (1) — — 52,358 Amortization of debt issuance costs (1) 3,914 3,894 2,783 Total $ 5,350 $ 5,333 $ 56,579 (1) The decrease in total interest expense beginning in fiscal 2023, was due to the derecognition of unamortized debt discount partially offset by the increase in the amortization of issuance costs previously recognized in equity. These changes were the result of adoption of ASU 2020-06, as described in Note 1, Business and Summary of Significant Accounting Policies.

Operating Leases (Tables)

Operating Leases (Tables)	12 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Schedule of Operating Lease Costs	The following is a summary of our operating lease costs: Year Ended July 31, 2024 2023 2022 Real Estate Arrangements Co-Location Arrangements Total Real Estate Arrangements Co-Location Arrangements Total Real Estate Arrangements Co-Location Arrangements Total (in thousands) Operating lease, including imputed interest $ 9,902 $ 39,577 $ 49,479 $ 7,858 $ 24,677 $ 32,535 $ 6,347 $ 19,356 $ 25,703 Short-term lease cost 5,138 8,090 13,228 4,314 5,688 10,002 2,826 1,889 4,715 Variable lease cost 9,907 6,047 15,954 6,992 4,956 11,948 3,163 4,480 7,643 Total operating lease costs $ 24,947 $ 53,714 $ 78,661 $ 19,164 $ 35,321 $ 54,485 $ 12,336 $ 25,725 $ 38,061 Weighted-average remaining lease term (in years) 2.1 1.9 3.0 2.0 3.7 2.7 Weighted-average discount rate 5.3 % 4.7 % 4.5 % 3.2 % 4.1 % 2.2 %
Schedule of Lease Assets and Liabilities	The following table presents information about our leases in the consolidated balance sheets: July 31, 2024 2023 Real Estate Arrangements Co-Location Arrangements Total Real Estate Arrangements Co-Location Arrangements Total (in thousands) Operating lease right-of-use assets $ 22,612 $ 67,146 $ 89,758 $ 18,493 $ 52,178 $ 70,671 Operating lease liabilities, current $ 11,381 $ 39,485 $ 50,866 $ 6,777 $ 27,692 $ 34,469 Operating lease liabilities, noncurrent $ 12,974 $ 31,850 $ 44,824 $ 14,875 $ 27,042 $ 41,917
Schedule of Lease Maturities	Maturities of operating lease liabilities consisted of the following as of July 31, 2024: Real Estate Arrangements Co-Location Arrangements Total Year ending July 31, (in thousands) 2025 $ 12,381 $ 41,920 $ 54,301 2026 10,537 24,396 34,933 2027 2,481 8,598 11,079 2028 481 — 481 Total future minimum lease payments 25,880 74,914 100,794 Less: Imputed interest 1,525 3,579 5,104 Total $ 24,355 $ 71,335 $ 95,690

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Maturities of Non-Cancelable Purchase Obligations	The maturities of non-cancelable purchase obligations with a remaining term in excess of one year as of July 31, 2024 consisted of the following: Amount Year ending July 31, (in thousands) 2025 $ 57,961 2026 77,644 2027 51,088 2028 38,967 2029 18,750 Total $ 244,410

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of Stock Options	The activity of stock options for fiscal 2024 consisted of the following: Outstanding Weighted-Average Weighted-Average Aggregate (in thousands, except per share amounts) Balance as of July 31, 2023 1,267 $18.54 2.1 $ 179,678 Granted 50 $198.03 Exercised (864) $14.17 $ 157,832 Canceled, forfeited or expired — — Balance as of July 31, 2024 453 $46.72 2.5 $ 60,923 Exercisable and expected to vest as of July 31, 2023 1,210 $12.82 1.8 $ 178,616 Exercisable and expected to vest as of July 31, 2024 367 $15.84 1.0 $ 59,989
Schedule of Valuation Assumptions	We estimate the fair value of stock options using the Black-Scholes option pricing model with the following assumptions: Year Ended July 31 2024 2023 Expected term (in years) 6.0 6.1 Expected stock price volatility 59.5% 58.2% Risk-free interest rate 4.2% 3.9% Dividend yield 0.0% 0.0%
Schedule of Restricted Stock Units and Performance Stock Awards Activity	The activity of RSUs and PSAs consisted of the following for fiscal 2024: Underlying Shares Weighted-Average Grant Date Fair Value Aggregate (in thousands, except per share data) Balance as of July 31, 2023 9,351 $139.95 $ 1,499,714 Granted 6,018 $181.24 Vested (3,624) $136.82 $ 684,393 Canceled or forfeited (1,931) $160.35 Balance as of July 31, 2024 9,814 $162.41 $ 1,760,079
Schedule of ESPP Valuation Assumptions	The fair value of the purchase rights offered under the ESPP was estimated on the grant date using the Black-Scholes option-pricing model with the following assumptions: Year Ended July 31, 2024 2023 2022 Expected term (in years) 0.5 - 2.0 0.5 - 2.0 0.5 - 2.0 Expected stock price volatility 42.5% - 64.8% 58.1% - 75.9% 44.1% - 79.4% Risk-free interest rate 4.4% - 5.4% 4.2% - 5.3% 0.1% - 3.2% Dividend yield 0.0% 0.0% 0.0% The expected term represents the term from the first day of the offering period to the purchase dates within each offering period. The expected volatility was based on the historical volatility of our common stock. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for the expected term of the stock-based award. Our expected dividend yield is zero, as we have not and do not currently intend to declare dividends in the foreseeable future.
Schedule of Allocation of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the consolidated statements of operations consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands) Cost of revenue $ 50,820 $ 39,168 $ 23,847 Sales and marketing 219,096 215,597 191,091 Research and development 180,554 117,915 118,299 General and administrative 77,206 71,118 76,325 Restructuring and other charges — 1,036 — Total $ 527,676 $ 444,834 $ 409,562

Common Stock (Tables)

Common Stock (Tables)	12 Months Ended
	Jul. 31, 2024
Equity [Abstract]
Schedule of Common Stock	The following table summarizes our shares of common stock reserved for future issuance: July 31, 2024 (in thousands) Equity awards outstanding: Stock options 453 Unvested RSUs 8,805 Committed unvested PSAs, based on the target number of shares 607 Unvested PSAs 1,009 Share purchase rights committed under the ESPP 514 Equity awards available for future grants: 2018 Plan 30,892 ESPP 6,255 Stock reserved for settlement of the Notes 7,626 Total 56,161

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Income before Income (Loss) Tax, Domestic and Foreign	The following table sets forth the geographical breakdown of the income (loss) before the provision for income taxes: Year ended July 31, 2024 2023 2022 (in thousands) Domestic $ (112,758) $ (228,715) $ (413,148) International 83,529 46,151 29,518 Loss before provision for income taxes $ (29,229) $ (182,564) $ (383,630)
Schedule of Components of Income Tax Expense (Benefit)	The following table sets forth the components of the provision for income taxes: Year ended July 31, 2024 2023 2022 Current: (in thousands) Federal $ 203 $ 1,091 $ — State 1,337 3,890 399 Foreign 32,620 14,438 6,996 Total current tax expense 34,160 19,419 7,395 Deferred: Federal (4,526) — (858) State (693) — (185) Foreign (464) 352 296 Total deferred tax benefit (expense) (5,683) 352 (747) Total provision for income taxes $ 28,477 $ 19,771 $ 6,648
Schedule of Effective Income Tax Rate Reconciliation	The following table presents the reconciliation of the statutory federal income tax rate to our effective rate: Year ended July 31, 2024 2023 2022 Tax at federal statutory rate 21.0 % 21.0 % 21.0 % State taxes (0.4) (2.1) (0.1) Impact of foreign rate differential 36.2 10.1 (0.4) Stock-based compensation 162.6 (0.8) 17.6 U.S. tax credits 101.8 8.6 3.9 Change in valuation allowance (471.3) (34.1) (43.6) Withholding tax (12.5) (1.3) (0.2) Waived deductions under Section 59A 74.3 (11.8) — Transaction costs (1.3) — — Meals and entertainment (7.0) (0.8) (0.2) Other (0.8) 0.3 0.3 Effective tax rate (97.4) % (10.9) % (1.7) %
Schedule of Deferred Tax Assets and Liabilities	The following table presents the tax effects of temporary differences that give rise to significant portions of our deferred tax assets and liabilities: July 31, 2024 2023 (in thousands) Deferred tax assets: Net operating losses carryovers $ 373,611 $ 401,261 Deferred revenue 181,654 122,326 Research and development capitalization 168,918 92,901 Tax credits carryovers 157,861 98,564 Other 100,930 75,641 Gross deferred tax assets 982,974 790,693 Less: Valuation allowance (833,908) (671,381) Total deferred tax assets $ 149,066 $ 119,312 Deferred tax liabilities: Intangible assets $ (10,273) $ (4,765) Deferred contract acquisition costs (99,123) (86,805) Property and equipment (9,929) (4,690) Operating lease right-of-use assets (29,137) (22,403) Total deferred tax liabilities $ (148,462) $ (118,663) Net deferred tax assets $ 604 $ 649
Schedule of Valuation Allowance	The following table presents the change in the valuation allowance: Year ended July 31, 2024 2023 2022 (in thousands) Balance as of the beginning of the period $ 671,381 $ 553,916 $ 345,756 Change during the period 162,527 117,465 208,160 Balance as of the end of the period $ 833,908 $ 671,381 $ 553,916
Schedule of Unrecognized Tax Benefits Roll Forward	The changes in our gross unrecognized tax benefits consisted of the following: Amount (in thousands) Balance as of July 31, 2022 $ 29,699 Gross increase for tax positions of prior years 1,653 Gross (decrease) for tax positions of prior years — Gross increase for tax positions of current year 9,337 Balance as of July 31, 2023 40,689 Gross increase for tax positions of prior years 6,960 Gross (decrease) for tax positions of prior years (2,102) Gross increase for tax positions of current year 18,378 Balance as of July 31, 2024 $ 63,925

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	12 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	The computation of basic and diluted net loss per share consisted of the following: Year Ended July 31, 2024 2023 2022 (in thousands, except per share data) Net loss $ (57,706) $ (202,335) $ (390,278) Weighted-average shares used in computing net loss per share, basic and diluted 149,586 144,942 140,895 Net loss per share, basic and diluted $ (0.39) $ (1.40) $ (2.77)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following table summarizes the outstanding potentially dilutive securities that were excluded from the computation of diluted net loss per share as their effect would be antidilutive: July 31, 2024 2023 2022 (in thousands) Unvested RSUs and shares of common stock 9,198 8,442 6,769 Stock options 453 1,267 1,673 Unvested PSAs (1) 1,009 1,012 832 Share purchase rights under the ESPP 514 1,119 850 Notes (2) 7,626 7,626 7,626 Total 18,800 19,466 17,750 (1) The number of unvested PSAs is estimated at 100% of the target number of shares granted and excludes unvested PSAs for which performance conditions have not been established as of July 31, 2024, as they are not considered outstanding for accounting purposes. For further information refer to Note 13, Stock-Based Compensation. (2) The shares underlying the conversion option in the Notes were not considered in the calculation of diluted net loss per share for all the periods presented, as their effect would have been antidilutive. Based on the initial conversion price, the entire outstanding principal amount of the Notes as of July 31, 2024 would have been convertible into approximately 7.6 million shares of our common stock, which is reflected in the above table. As we expect to settle the principal amount of the Notes in cash, only the amount by which the conversion value exceeds the aggregate principal amount of the Notes (the "conversion spread") is considered in the diluted earnings per share computation under the treasury stock method. The conversion spread has a dilutive impact on diluted net income per share when the average market price of our common stock for a given reporting period exceeds the initial conversion price of $150.80

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	12 Months Ended
	Jul. 31, 2024
Risks and Uncertainties [Abstract]
Schedule of Long-Lived Assets	Our long-lived assets consist of property and equipment and operating lease right-of-use assets, which are summarized by geographic area as follows: July 31, 2024 2023 (in thousands) United States $ 325,146 $ 213,611 Rest of the world 147,735 99,415 Total $ 472,881 $ 313,026

Business and Summary of Signi_3

Business and Summary of Significant Accounting Policies (Details) shares in Thousands			12 Months Ended
	Aug. 01, 2022 USD ($) shares	Jun. 25, 2020 shares	Jul. 31, 2024 USD ($) segment shares	Jul. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)	Oct. 31, 2023	Jul. 31, 2021 USD ($)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Number of operating segments | segment			1
Number of reportable segments | segment			1
Investment impairment			$ 0	$ 0	$ 0
Capitalized software costs			76,900,000	48,600,000	32,700,000
Capitalized software, amortization expense			36,300,000	24,200,000	13,000,000
Impairment of goodwill			0	0	0
Asset impairment charges			$ 0	0	0
Requisite service period			4 years
Award offering period			2 years
Principal amount			$ 1,149,954,000	1,149,993,000
Cumulative effect adjustment			$ 1,274,102,000	725,112,000	573,300,000		$ 528,895,000
Number of shares if notes converted (in shares) | shares	7,630	7,626	7,600
Advertising expense			$ 25,000,000	24,000,000	22,100,000
Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment			2,426,819,000	1,816,915,000	1,590,885,000		1,131,006,000
Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment			$ (1,148,080,000)	$ (1,090,374,000)	(991,878,000)		$ (601,600,000)
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Principal amount	$ 169,900,000
Cumulative effect adjustment					(169,899,000)
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	(273,700,000)				(273,738,000)
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cumulative effect adjustment	$ 103,800,000				$ 103,839,000
Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract with customer, term of contract			1 year
Estimated Useful Life			3 years
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Contract with customer, term of contract			3 years
Estimated Useful Life			5 years
Servers And Networking Equipment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated Useful Life				4 years		5 years
Servers And Networking Equipment | Long Lived Tangible Assets Amortization Period
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decreased depreciation expense			$ 13,400,000
Capitalized internal-use software | Minimum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated Useful Life			3 years
Capitalized internal-use software | Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Estimated Useful Life			5 years

Revenue Recognition - Narrative

Revenue Recognition - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue [Line Items]
Deferred revenue	$ 1,895	$ 1,439.7
Contract with customer, liability, revenue recognized	1,277.8	$ 919.9	$ 570.3
Revenue, remaining performance obligation	$ 4,417.6
Capitalized contract cost, amortization period	5 years
Minimum
Disaggregation of Revenue [Line Items]
Payment terms	30 days
Contract with customer, term of contract	1 year
Maximum
Disaggregation of Revenue [Line Items]
Payment terms	90 days
Contract with customer, term of contract	3 years
Transferred Over Time | Product Concentration Risk | Subscription and Support | Revenue Benchmark
Disaggregation of Revenue [Line Items]
Concentration risk percentage	97%	97%	97%

Revenue Recognition - Schedule

Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 2,167,771	$ 1,616,952	$ 1,090,946
Geographic Concentration Risk | Revenue Benchmark
Disaggregation of Revenue [Line Items]
Revenue	$ 2,167,771	$ 1,616,952	$ 1,090,946
Revenue percentage	100%	100%	100%
Geographic Concentration Risk | Revenue Benchmark | United States
Disaggregation of Revenue [Line Items]
Revenue	$ 1,092,304	$ 808,527	$ 536,924
Revenue percentage	50%	50%	49%
Geographic Concentration Risk | Revenue Benchmark | Europe, Middle East and Africa
Disaggregation of Revenue [Line Items]
Revenue	$ 672,421	$ 515,136	$ 370,035
Revenue percentage	31%	32%	34%
Geographic Concentration Risk | Revenue Benchmark | Asia Pacific
Disaggregation of Revenue [Line Items]
Revenue	$ 327,816	$ 241,250	$ 155,460
Revenue percentage	15%	15%	14%
Geographic Concentration Risk | Revenue Benchmark | Other
Disaggregation of Revenue [Line Items]
Revenue	$ 75,230	$ 52,039	$ 28,527
Revenue percentage	4%	3%	3%
Customer Concentration Risk | Revenue Benchmark
Disaggregation of Revenue [Line Items]
Revenue	$ 2,167,771	$ 1,616,952	$ 1,090,946
Revenue percentage	100%	100%	100%
Customer Concentration Risk | Revenue Benchmark | Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 1,967,908	$ 1,488,379	$ 1,016,747
Revenue percentage	91%	92%	93%
Customer Concentration Risk | Revenue Benchmark | Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 199,863	$ 128,573	$ 74,199
Revenue percentage	9%	8%	7%

Revenue Recognition - Remaining

Revenue Recognition - Remaining Performance Obligation (Details)	Jul. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	48%
Recognized transaction price period	12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-08-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	94%
Recognized transaction price period	3 years

Revenue Recognition - Schedul_2

Revenue Recognition - Schedule of Deferred Contract Acquisition Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Changes in Capitalized Contract Cost [Roll Forward]
Beginning balance	$ 375,234	$ 297,002	$ 207,030
Capitalization of contract acquisition costs	200,303	176,950	158,503
Amortization of deferred contract acquisition costs	(130,139)	(98,718)	(68,531)
Ending balance	445,398	375,234	297,002
Deferred contract acquisition costs, current	148,873	115,827
Deferred contract acquisition costs, noncurrent	296,525	259,407
Total deferred contract acquisition costs	$ 445,398	$ 375,234	$ 297,002

Cash Equivalents and Short-Te_3

Cash Equivalents and Short-Term Investments - Schedule of Cash Equivalents and Short-term Investments (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Cash equivalents:
Amortized Cost	$ 1,273,615	$ 1,130,724
Unrealized Gains	0	0
Unrealized Losses	(21)	(65)
Fair Value	1,273,594	1,130,659
Short-term investments:
Amortized Cost	987,004	848,360
Unrealized Gains	1,565	51
Unrealized Losses	(1,995)	(10,385)
Fair Value	986,574	838,026
Total cash equivalents and short-term investments, amortized cost	2,260,619	1,979,084
Total cash equivalents and short-term investments, unrealized gains	1,565	51
Total cash equivalents and short-term investments, unrealized losses	(2,016)	(10,450)
Total cash equivalents and short-term investments	2,260,168	1,968,685
U.S. treasury securities
Short-term investments:
Amortized Cost	257,841	175,451
Unrealized Gains	8	0
Unrealized Losses	(828)	(1,875)
Fair Value	257,021	173,576
U.S. government agency securities
Short-term investments:
Amortized Cost	160,574	266,392
Unrealized Gains	43	2
Unrealized Losses	(542)	(4,299)
Fair Value	160,075	262,095
Corporate debt securities
Short-term investments:
Amortized Cost	568,589	406,517
Unrealized Gains	1,514	49
Unrealized Losses	(625)	(4,211)
Fair Value	569,478	402,355
Money market funds
Cash equivalents:
Amortized Cost	956,932	768,003
Unrealized Gains	0	0
Unrealized Losses	0	0
Fair Value	956,932	768,003
U.S. treasury securities
Cash equivalents:
Amortized Cost	178,188	157,250
Unrealized Gains	0	0
Unrealized Losses	(15)	(30)
Fair Value	178,173	157,220
U.S. government agency securities
Cash equivalents:
Amortized Cost	57,555	166,671
Unrealized Gains	0	0
Unrealized Losses	(6)	(35)
Fair Value	57,549	166,636
Certificates of deposit
Cash equivalents:
Amortized Cost	80,940
Unrealized Gains	0
Unrealized Losses	0
Fair Value	$ 80,940
Corporate debt securities
Cash equivalents:
Amortized Cost		38,800
Unrealized Gains		0
Unrealized Losses		0
Fair Value		$ 38,800

Cash Equivalents and Short-Te_4

Cash Equivalents and Short-Term Investments - Schedule of Maturities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Amortized Cost
Due within one year	$ 476,116
Due between one to three years	510,888
Amortized Cost	987,004	$ 848,360
Fair Value
Due within one year	475,325
Due between one to three years	511,249
Fair Value	$ 986,574	$ 838,026

Cash Equivalents and Short-Te_5

Cash Equivalents and Short-Term Investments - Schedule of Unrealized Position (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	$ 299,157	$ 525,638
Less than 12 months, unrealized losses	(245)	(4,201)
Greater than 12 months, fair value	247,808	214,129
Greater than 12 months, unrealized losses	(1,750)	(6,184)
Total fair value	546,965	739,767
Total unrealized losses	(1,995)	(10,385)
U.S. treasury securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	152,574	173,576
Less than 12 months, unrealized losses	(115)	(1,875)
Greater than 12 months, fair value	87,808	0
Greater than 12 months, unrealized losses	(713)	0
Total fair value	240,382	173,576
Total unrealized losses	(828)	(1,875)
U.S. government agency securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	65,563	119,558
Less than 12 months, unrealized losses	(28)	(292)
Greater than 12 months, fair value	65,334	131,530
Greater than 12 months, unrealized losses	(514)	(4,007)
Total fair value	130,897	251,088
Total unrealized losses	(542)	(4,299)
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Less than 12 months, fair value	81,020	232,504
Less than 12 months, unrealized losses	(102)	(2,034)
Greater than 12 months, fair value	94,666	82,599
Greater than 12 months, unrealized losses	(523)	(2,177)
Total fair value	175,686	315,103
Total unrealized losses	$ (625)	$ (4,211)

Cash Equivalents and Short-Te_6

Cash Equivalents and Short-Term Investments - Narrative (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Cash and Cash Equivalents [Abstract]
Accrued interest receivable	$ 10.7	$ 7.2
Investment carrying value	$ 9.8	$ 7.8

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Cash equivalents:
Fair Value	$ 1,273,594	$ 1,130,659
Short-term investments:
Short-term investments	986,574	838,026
Total cash equivalents and short-term investments	2,260,168	1,968,685
Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	1,273,594	1,130,659
Short-term investments:
Short-term investments	986,574	838,026
Total cash equivalents and short-term investments	2,260,168	1,968,685
Fair Value, Measurements, Recurring | Foreign Currency Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	2,541	12,581
Foreign currency contracts assets-noncurrent	800	2,264
Derivative liabilities - current	3,731	1,452
Foreign currency contracts liabilities-noncurrent	844	669
Non-designated derivative instruments:
Foreign currency contracts assets-current	2,541	12,581
Foreign currency contracts liabilities-current	3,731	1,452
Fair Value, Measurements, Recurring | Foreign Currency Contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	2,132	2,061
Derivative liabilities - current	1,748	465
Non-designated derivative instruments:
Foreign currency contracts assets-current	2,132	2,061
Foreign currency contracts liabilities-current	1,748	465
Fair Value, Measurements, Recurring | Interest Rate Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative liabilities - current	3,829	6,439
Foreign currency contracts liabilities-noncurrent		1,588
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	3,829	6,439
Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	956,932	768,003
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	956,932	768,003
Fair Value, Measurements, Recurring | Level I | Foreign Currency Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts assets-noncurrent	0	0
Derivative liabilities - current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Foreign Currency Contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Derivative liabilities - current	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level I | Interest Rate Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative liabilities - current	0	0
Foreign currency contracts liabilities-noncurrent		0
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	316,662	362,656
Short-term investments:
Short-term investments	986,574	838,026
Total cash equivalents and short-term investments	1,303,236	1,200,682
Fair Value, Measurements, Recurring | Level II | Foreign Currency Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	2,541	12,581
Foreign currency contracts assets-noncurrent	800	2,264
Derivative liabilities - current	3,731	1,452
Foreign currency contracts liabilities-noncurrent	844	669
Non-designated derivative instruments:
Foreign currency contracts assets-current	2,541	12,581
Foreign currency contracts liabilities-current	3,731	1,452
Fair Value, Measurements, Recurring | Level II | Foreign Currency Contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	2,132	2,061
Derivative liabilities - current	1,748	465
Non-designated derivative instruments:
Foreign currency contracts assets-current	2,132	2,061
Foreign currency contracts liabilities-current	1,748	465
Fair Value, Measurements, Recurring | Level II | Interest Rate Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative liabilities - current	3,829	6,439
Foreign currency contracts liabilities-noncurrent		1,588
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	3,829	6,439
Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Short-term investments:
Short-term investments	0	0
Total cash equivalents and short-term investments	0	0
Fair Value, Measurements, Recurring | Level III | Foreign Currency Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts assets-noncurrent	0	0
Derivative liabilities - current	0	0
Foreign currency contracts liabilities-noncurrent	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Foreign Currency Contracts | Not Designated as Hedging Instrument
Designated derivative instruments:
Foreign currency contracts assets-current	0	0
Derivative liabilities - current	0	0
Non-designated derivative instruments:
Foreign currency contracts assets-current	0	0
Foreign currency contracts liabilities-current	0	0
Fair Value, Measurements, Recurring | Level III | Interest Rate Contracts | Designated as Hedging Instrument
Designated derivative instruments:
Derivative liabilities - current	0	0
Foreign currency contracts liabilities-noncurrent		0
Non-designated derivative instruments:
Foreign currency contracts liabilities-current	0	0
U.S. treasury securities
Short-term investments:
Short-term investments	257,021	173,576
U.S. treasury securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	257,021	173,576
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	257,021	173,576
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
U.S. government agency securities
Short-term investments:
Short-term investments	160,075	262,095
U.S. government agency securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	160,075	262,095
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	160,075	262,095
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Corporate debt securities
Short-term investments:
Short-term investments	569,478	402,355
Corporate debt securities | Fair Value, Measurements, Recurring
Short-term investments:
Short-term investments	569,478	402,355
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Short-term investments:
Short-term investments	0	0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Short-term investments:
Short-term investments	569,478	402,355
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Short-term investments:
Short-term investments	0	0
Money market funds
Cash equivalents:
Fair Value	956,932	768,003
Money market funds | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	956,932	768,003
Money market funds | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	956,932	768,003
Money market funds | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	0	0
Money market funds | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. treasury securities
Cash equivalents:
Fair Value	178,173	157,220
U.S. treasury securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	178,173	157,220
U.S. treasury securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. treasury securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	178,173	157,220
U.S. treasury securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
U.S. government agency securities
Cash equivalents:
Fair Value	57,549	166,636
U.S. government agency securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	57,549	166,636
U.S. government agency securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0	0
U.S. government agency securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	57,549	166,636
U.S. government agency securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	0	0
Certificates of deposit
Cash equivalents:
Fair Value	80,940
Certificates of deposit | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value	80,940
Certificates of deposit | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value	0
Certificates of deposit | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value	80,940
Certificates of deposit | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value	$ 0
Corporate debt securities
Cash equivalents:
Fair Value		38,800
Corporate debt securities | Fair Value, Measurements, Recurring
Cash equivalents:
Fair Value		38,800
Corporate debt securities | Fair Value, Measurements, Recurring | Level I
Cash equivalents:
Fair Value		0
Corporate debt securities | Fair Value, Measurements, Recurring | Level II
Cash equivalents:
Fair Value		38,800
Corporate debt securities | Fair Value, Measurements, Recurring | Level III
Cash equivalents:
Fair Value		$ 0

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Oct. 31, 2023	Jul. 31, 2023
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 633,432		$ 418,779
Less: Accumulated depreciation and amortization	(250,311)		(176,424)
Total property and equipment, net	383,121		$ 242,355
Hosting equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life		5 years	4 years
Total property and equipment, gross	418,775		$ 280,851
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	197,769		120,877
Computers and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 6,741		7,107
Purchased software
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Total property and equipment, gross	$ 1,102		1,311
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Estimated Useful Life	5 years
Total property and equipment, gross	$ 1,071		1,025
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment, gross	$ 7,974		$ 7,608
Minimum
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Minimum | Hosting equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life	4 years
Minimum | Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Minimum | Computers and equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Maximum
Property, Plant and Equipment [Line Items]
Estimated Useful Life	5 years
Maximum | Hosting equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life	5 years
Maximum | Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Estimated Useful Life	5 years
Maximum | Computers and equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life	5 years

Balance Sheet Components - Narr

Balance Sheet Components - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Historical cost	$ 109,616	$ 57,016
Accumulated amortization	45,781	31,157
Depreciation and amortization expense	66,308	55,756	$ 40,456
Capitalization of development costs of software for internal-use	$ 527,676	444,834	409,562
IP Addresses
Acquired Finite-Lived Intangible Assets [Line Items]
Useful life	10 years
Historical cost	$ 12,400	8,600
Accumulated amortization	2,800	1,600
Capitalized internal-use software
Acquired Finite-Lived Intangible Assets [Line Items]
Capitalization of development costs of software for internal-use	$ 13,000	$ 8,400	$ 4,500

Balance Sheet Components- Sched

Balance Sheet Components- Schedule of Accrued Compensation (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Property, Plant and Equipment [Abstract]
Accrued commissions	$ 51,371	$ 47,997
Accrued bonuses	53,452	37,417
Accrued payroll and related expenses	47,184	44,024
Employee stock purchase plan	8,803	7,362
Total accrued compensation	$ 160,810	$ 136,800

Business Combinations - Narrati

Business Combinations - Narrative (Details) - USD ($) $ in Thousands						1 Months Ended	12 Months Ended
	Apr. 12, 2024	Mar. 08, 2024	Aug. 31, 2023	Feb. 20, 2023	Jun. 17, 2022	Nov. 30, 2021	Jul. 31, 2024	Jul. 31, 2023
Business Acquisition [Line Items]
Goodwill							$ 417,029	$ 89,192
Estimated useful life							4 years 2 months 12 days
Developed technology
Business Acquisition [Line Items]
Estimated useful life							4 years 2 months 12 days	3 years
Customer relationships
Business Acquisition [Line Items]
Estimated useful life							4 years 4 months 24 days	2 years 3 months 18 days
Airgap Networks Inc.
Business Acquisition [Line Items]
Payments to acquire businesses, cash	$ 124,400
Fair value of contingent consideration	20,300
Purchase price consideration, fair value	6,200
Purchase price consideration, pre-combination vesting	1,400
Goodwill	95,463
Airgap Networks Inc. | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles	$ 28,700
Estimated useful life	5 years
Airgap Networks Inc. | Customer relationships
Business Acquisition [Line Items]
Finite-lived intangibles	$ 3,100
Estimated useful life	5 years
Avalor Technologies Ltd.
Business Acquisition [Line Items]
Payments to acquire businesses, cash		$ 256,700
Fair value of contingent consideration		46,500
Purchase price consideration, fair value		14,400
Purchase price consideration, pre-combination vesting		2,400
Goodwill		229,151
Avalor Technologies Ltd. | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles		$ 14,700
Estimated useful life		5 years
Avalor Technologies Ltd. | Customer relationships
Business Acquisition [Line Items]
Finite-lived intangibles		$ 3,300
Estimated useful life		5 years
Securelyshare Software Private Ltd
Business Acquisition [Line Items]
Payments to acquire businesses, cash			$ 5,300
Goodwill			3,200
Securelyshare Software Private Ltd | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles			$ 2,800
Estimated useful life			5 years
Canonic Security Technologies Ltd.
Business Acquisition [Line Items]
Payments to acquire businesses, cash				$ 16,500
Fair value of contingent consideration				4,100
Goodwill				10,645
Canonic Security Technologies Ltd. | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles				$ 5,100
Estimated useful life				5 years
ShiftRight, Inc.
Business Acquisition [Line Items]
Payments to acquire businesses, cash					$ 25,600
Fair value of contingent consideration					15,200
Goodwill					18,724
ShiftRight, Inc. | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles					$ 7,100
Estimated useful life					5 years
Business Acquisition 2022
Business Acquisition [Line Items]
Payments to acquire businesses, cash						$ 400
Goodwill						800
Purchase price						2,100
Fair value of shares issued						1,700
Business Acquisition 2022 | Developed technology
Business Acquisition [Line Items]
Finite-lived intangibles						$ 1,600
Estimated useful life						5 years

Business Combinations - Net Ass

Business Combinations - Net Assets Acquired (Details) - USD ($) $ in Thousands					12 Months Ended
	Apr. 12, 2024	Mar. 08, 2024	Feb. 20, 2023	Jun. 17, 2022	Jul. 31, 2024	Jul. 31, 2023
Assets acquired:
Goodwill					$ 417,029	$ 89,192
Liabilities assumed:
Estimated Useful Life					4 years 2 months 12 days
Developed technology
Liabilities assumed:
Estimated Useful Life					4 years 2 months 12 days	3 years
Customer relationships
Liabilities assumed:
Estimated Useful Life					4 years 4 months 24 days	2 years 3 months 18 days
Airgap Networks Inc.
Assets acquired:
Cash, cash equivalents and other assets	$ 5,764
Goodwill	95,463
Total	133,027
Liabilities assumed:
Accounts payable, accrued expenses and other liabilities	3,467
Deferred tax liability	5,123
Total	8,590
Total purchase price consideration	124,437
Airgap Networks Inc. | Developed technology
Assets acquired:
Acquired intangible assets	$ 28,700
Liabilities assumed:
Estimated Useful Life	5 years
Airgap Networks Inc. | Customer relationships
Assets acquired:
Acquired intangible assets	$ 3,100
Liabilities assumed:
Estimated Useful Life	5 years
Avalor Technologies Ltd.
Assets acquired:
Cash, cash equivalents and other assets		$ 13,405
Deferred tax asset		841
Goodwill		229,151
Total		261,397
Liabilities assumed:
Accounts payable, accrued expenses and other liabilities		4,017
Deferred tax liability		693
Total		4,710
Total purchase price consideration		256,687
Avalor Technologies Ltd. | Developed technology
Assets acquired:
Acquired intangible assets		$ 14,700
Liabilities assumed:
Estimated Useful Life		5 years
Avalor Technologies Ltd. | Customer relationships
Assets acquired:
Acquired intangible assets		$ 3,300
Liabilities assumed:
Estimated Useful Life		5 years
Canonic Security Technologies Ltd.
Assets acquired:
Cash, cash equivalents and other assets			$ 673
Deferred tax asset			781
Goodwill			10,645
Total			17,199
Liabilities assumed:
Accounts payable, accrued expenses and other liabilities			692
Total			692
Total purchase price consideration			16,507
Canonic Security Technologies Ltd. | Developed technology
Assets acquired:
Acquired intangible assets			$ 5,100
Liabilities assumed:
Estimated Useful Life			5 years
ShiftRight, Inc.
Assets acquired:
Cash, cash equivalents and other assets				$ 535
Goodwill				18,724
Total				26,359
Liabilities assumed:
Deferred tax liability				682
Other liabilities				99
Total				781
Total purchase price consideration				25,578
ShiftRight, Inc. | Developed technology
Assets acquired:
Acquired intangible assets				$ 7,100
Liabilities assumed:
Estimated Useful Life				5 years

Goodwill and Acquired Intangi_3

Goodwill and Acquired Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	12 Months Ended
	Jul. 31, 2024 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 89,192
Goodwill acquired	327,837
Goodwill, ending balance	$ 417,029

Goodwill and Acquired intangi_4

Goodwill and Acquired intangible Assets - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated useful life	4 years 2 months 12 days
Amortization expense of acquired intangible assets	$ 14,624	$ 11,060	$ 9,010
Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated useful life	4 years 2 months 12 days	3 years
Amortization expense of acquired intangible assets	$ 13,392
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated useful life	4 years 4 months 24 days	2 years 3 months 18 days
Amortization expense of acquired intangible assets	$ 1,232
Airgap, Avalor And Securelyshare | Developed technology
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangibles	$ 46,200
Estimated useful life	5 years
Airgap, Avalor And Securelyshare | Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived intangibles	$ 6,400
Estimated useful life	5 years

Goodwill and Acquired Intangi_5

Goodwill and Acquired Intangible Assets - Schedule of Acquired Intangible Assets (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance	$ 57,016
Additions	52,600
Intangible Assets, Gross, ending balance	109,616	$ 57,016
Accumulated Amortization, beginning balance	(31,157)
Amortization Expense	(14,624)	(11,060)	$ (9,010)
Accumulated Amortization, ending balance	(45,781)	(31,157)
Total	$ 63,835	25,859
Weighted Average Remaining Useful life	4 years 2 months 12 days
Developed technology
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance	$ 53,456
Additions	46,200
Intangible Assets, Gross, ending balance	99,656	53,456
Accumulated Amortization, beginning balance	(29,259)
Amortization Expense	(13,392)
Accumulated Amortization, ending balance	(42,651)	(29,259)
Total	$ 57,005	$ 24,197
Weighted Average Remaining Useful life	4 years 2 months 12 days	3 years
Customer relationships
Finite-lived Intangible Assets [Roll Forward]
Intangible Assets, Gross, beginning balance	$ 3,560
Additions	6,400
Intangible Assets, Gross, ending balance	9,960	$ 3,560
Accumulated Amortization, beginning balance	(1,898)
Amortization Expense	(1,232)
Accumulated Amortization, ending balance	(3,130)	(1,898)
Total	$ 6,830	$ 1,662
Weighted Average Remaining Useful life	4 years 4 months 24 days	2 years 3 months 18 days

Goodwill and Acquired Intangi_6

Goodwill and Acquired Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
2025	$ 16,785
2026	15,772
2027	12,948
2028	11,115
2029	7,215
Total	$ 63,835	$ 25,859

Derivative Instruments - Narrat

Derivative Instruments - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Derivative [Line Items]
Unrealized gain related to our cash flow hedges	$ 2,200
Hedge accounting fair value adjustments	(4,065)	$ (8,306)
Long-term Debt
Derivative [Line Items]
Hedged liability, fair value hedge	498,200	496,400
Foreign Currency Contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	352,800	182,900
Foreign Currency Contracts | Designated as Hedging Instrument
Derivative [Line Items]
Notional amount	544,500	457,600
Interest Rate Swap
Derivative [Line Items]
Notional amount	$ 500,000	$ 500,000
Maximum
Derivative [Line Items]
Term of derivative	21 months
Maximum | Foreign Currency Contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative	4 months
Minimum | Foreign Currency Contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Term of derivative	1 month

Derivative Instruments - Schedu

Derivative Instruments - Schedule of Changes of AOCI Related to our Cash Flow Hedges (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 725,112	$ 573,300	$ 528,895
Net unrealized gains (losses) recognized in accumulated other comprehensive income	(10,761)	11,103	(20,130)
Gains (losses) reclassified from AOCI into the consolidated statement of operations	(2,400)	11,579	7,013
Ending balance	1,274,102	725,112	573,300
Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	8,937	(13,745)	(628)
Ending balance	$ (4,224)	$ 8,937	$ (13,745)

Derivative Instruments - Sche_2

Derivative Instruments - Schedule of Cash Flow Hedges on our Consolidated Statement of Operations (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (2,400)	$ 11,579	$ 7,013
Cost of revenue
Derivative Instruments, Gain (Loss) [Line Items]
Total	(785)	1,835	617
Sales and marketing
Derivative Instruments, Gain (Loss) [Line Items]
Total	(789)	7,670	520
Research and development
Derivative Instruments, Gain (Loss) [Line Items]
Total	(433)	1,506	284
General and administrative
Derivative Instruments, Gain (Loss) [Line Items]
Total	$ (393)	$ 568	$ 5,592

Derivative Instruments - Sche_3

Derivative Instruments - Schedule of Derivative Instruments Designated as Fair Value Hedges (Details) - Interest rate swaps: - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Hedge accounting fair value adjustments	$ (4,241)	$ 8,306
Derivatives designated as hedging instruments	4,198	(8,028)
Total	$ (43)	$ 278

Restructuring and Other Charg_2

Restructuring and Other Charges (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Mar. 01, 2023
Restructuring Cost and Reserve [Line Items]
Worldwide workforce reduction percentage				3%
Stock-based compensation expense	$ 527,676	$ 444,834	$ 409,562
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		Restructuring and other charges
Restructuring Plan 2023
Restructuring Cost and Reserve [Line Items]
Restructuring charges		$ 7,600
Employee severance and benefit charges		6,600
Stock-based compensation expense		$ 1,000

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details) $ / shares in Units, $ in Thousands	Jul. 05, 2023 USD ($) trading_day	Jun. 25, 2020 USD ($) trading_day $ / shares	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)	Aug. 01, 2022 USD ($)	Jul. 31, 2022 USD ($)	Jul. 31, 2021 USD ($)
Debt Instrument [Line Items]
Proceeds from debt issuance		$ 1,130,500
Threshold trading days | trading_day	20	20
Threshold consecutive trading days | trading_day	30	30
Threshold percentage of share price that triggers conversion	130%	130%
Number of trading days | trading_day		5
Number of consecutive trading days | trading_day		5
Percentage of closing price (less than)		98%
Redemption price, percentage of principal	100%	100%
Minimum principal amount outstanding not subject to partial redemption	$ 100,000
Effective interest rate		5.75%
Carrying amount of equity component		$ 278,500
Unamortized debt issuance costs		19,500	$ 3,614	$ 7,528
Equity issuance costs		4,700
Net carrying amount of equity component		273,400
Deferred tax impact		$ 400
Principal amount			1,149,954	1,149,993
Cumulative effect adjustment			(1,274,102)	(725,112)		$ (573,300)	$ (528,895)
Fair value of notes			1,465,500	1,411,400
Initial strike price (in dollars per share) | $ / shares		$ 150.80
Initial cap price (in dollars per share) | $ / shares		$ 246.76
Net cost of capped call		$ 145,200
Additional Paid-In Capital
Debt Instrument [Line Items]
Cumulative effect adjustment			(2,426,819)	(1,816,915)		(1,590,885)	(1,131,006)
Accumulated Deficit
Debt Instrument [Line Items]
Cumulative effect adjustment			$ 1,148,080	$ 1,090,374		991,878	$ 601,600
Cumulative Effect, Period of Adoption, Adjustment
Debt Instrument [Line Items]
Principal amount					$ 169,900
Cumulative effect adjustment						169,899
Cumulative Effect, Period of Adoption, Adjustment | Additional Paid-In Capital
Debt Instrument [Line Items]
Cumulative effect adjustment					273,700	273,738
Cumulative Effect, Period of Adoption, Adjustment | Accumulated Deficit
Debt Instrument [Line Items]
Cumulative effect adjustment					$ (103,800)	$ (103,839)
Long-term Debt
Debt Instrument [Line Items]
Unamortized debt issuance costs		14,800
Convertible Senior Notes Due 2025
Debt Instrument [Line Items]
Principal amount		$ 1,150,000
Interest rate		0.125%
Effective interest rate		6.03%
Convertible Senior Notes, $150 million
Debt Instrument [Line Items]
Principal amount		$ 150,000

Convertible Senior Notes - Sche

Convertible Senior Notes - Schedule of Notes (Details) shares in Thousands			12 Months Ended
	Aug. 01, 2022 shares	Jun. 25, 2020 shares $ / shares	Jul. 31, 2024 shares $ / shares
Debt Disclosure [Abstract]
Conversion ratio per $1,000 principal		0.0066
Initial conversion price (in dollars per share) | $ / shares		$ 150.80	$ 150.80
Initial number of shares (in shares) | shares	7,630	7,626	7,600

Convertible Senior Notes - Carr

Convertible Senior Notes - Carrying Amounts (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023	Jun. 25, 2020
Convertible Debt [Abstract]
Principal amount	$ 1,149,954	$ 1,149,993
Unamortized debt issuance costs	3,614	7,528	$ 19,500
Hedge accounting fair value adjustments	4,065	8,306
Total	$ 1,142,275	$ 1,134,159

Convertible Senior Notes - Inte

Convertible Senior Notes - Interest Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 1,436	$ 1,439	$ 1,438
Amortization of debt discount	0	0	52,358
Amortization of debt issuance costs	3,914	3,894	2,783
Total	$ 5,350	$ 5,333	$ 56,579

Operating Leases - Schedule of

Operating Leases - Schedule of Operating Lease Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Lessee, Lease, Description [Line Items]
Operating lease, including imputed interest	$ 49,479	$ 32,535	$ 25,703
Short-term lease cost	13,228	10,002	4,715
Variable lease cost	15,954	11,948	7,643
Total operating lease costs	78,661	54,485	38,061
Real Estate Arrangements
Lessee, Lease, Description [Line Items]
Operating lease, including imputed interest	9,902	7,858	6,347
Short-term lease cost	5,138	4,314	2,826
Variable lease cost	9,907	6,992	3,163
Total operating lease costs	$ 24,947	$ 19,164	$ 12,336
Weighted-average remaining lease term (in years)	2 years 1 month 6 days	3 years	3 years 8 months 12 days
Weighted-average discount rate	5.30%	4.50%	4.10%
Co-Location Arrangements
Lessee, Lease, Description [Line Items]
Operating lease, including imputed interest	$ 39,577	$ 24,677	$ 19,356
Short-term lease cost	8,090	5,688	1,889
Variable lease cost	6,047	4,956	4,480
Total operating lease costs	$ 53,714	$ 35,321	$ 25,725
Weighted-average remaining lease term (in years)	1 year 10 months 24 days	2 years	2 years 8 months 12 days
Weighted-average discount rate	4.70%	3.20%	2.20%

Operating Leases - Schedule o_2

Operating Leases - Schedule of Lease Assets and Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	$ 89,758	$ 70,671
Operating lease liabilities, current	50,866	34,469
Operating lease liabilities, noncurrent	44,824	41,917
Real Estate Arrangements
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	22,612	18,493
Operating lease liabilities, current	11,381	6,777
Operating lease liabilities, noncurrent	12,974	14,875
Co-Location Arrangements
Lessee, Lease, Description [Line Items]
Operating lease right-of-use assets	67,146	52,178
Operating lease liabilities, current	39,485	27,692
Operating lease liabilities, noncurrent	$ 31,850	$ 27,042

Operating Leases - Narrative (D

Operating Leases - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Leases [Abstract]
Operating lease, payments	$ 49,239	$ 32,197	$ 27,663
Lease not yet commenced, amount	$ 9,600
Operating lease, not yet commenced, term		3 years

Operating Leases - Schedule o_3

Operating Leases - Schedule of Lease Maturities (Details) $ in Thousands	Jul. 31, 2024 USD ($)
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2025	$ 54,301
2026	34,933
2027	11,079
2028	481
Total future minimum lease payments	100,794
Less: Imputed interest	5,104
Total	95,690
Real Estate Arrangements
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2025	12,381
2026	10,537
2027	2,481
2028	481
Total future minimum lease payments	25,880
Less: Imputed interest	1,525
Total	24,355
Co-Location Arrangements
Lessee, Operating Lease, Liability, Payment, Due [Abstract]
2025	41,920
2026	24,396
2027	8,598
2028	0
Total future minimum lease payments	74,914
Less: Imputed interest	3,579
Total	$ 71,335

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Letter of Credit
Loss Contingencies [Line Items]
Aggregate value of unsecured letters of credits	$ 2.5	$ 2.1

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Maturities of Non-Cancelable Purchase Obligations (Details) $ in Thousands	Jul. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2025	$ 57,961
2026	77,644
2027	51,088
2028	38,967
2029	18,750
Total	$ 244,410

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) $ / shares in Units, $ in Thousands, shares in Millions	1 Months Ended				12 Months Ended
	Jun. 30, 2024 USD ($)	Feb. 29, 2024 USD ($)	Dec. 31, 2022 USD ($)	Oct. 31, 2022 USD ($)	Jul. 31, 2024 USD ($) period $ / shares shares	Jul. 31, 2023 USD ($) $ / shares shares	Jul. 31, 2022 USD ($) $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares) | shares					30.9
Weighted average grant date fair value (in dollars per share) | $ / shares					$ 117.41	$ 88.97	$ 0
Aggregate fair value of options vested					$ 1,400	$ 1,500	$ 3,900
Options exercised, aggregate intrinsic value					$ 157,832	56,500	230,100
Unrecognized compensation cost, weighted-average					2 years 9 months 18 days
Reversal of stock-based compensation expense					$ (527,676)	(444,834)	(409,562)
Unrecognized compensation cost					1,519,800
Capitalized stock-based compensation					27,200	17,200	11,500
Research and development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incremental stock-based compensation						6,000
Reversal of stock-based compensation expense					(180,554)	(117,915)	(118,299)
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Incremental stock-based compensation						1,300
Reversal of stock-based compensation expense					$ (219,096)	(215,597)	(191,091)
Chief Operating Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of stock-based compensation expense		$ 11,700
President
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reversal of stock-based compensation expense				$ 9,900
Unvested RSUs and shares of common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period					4 years
RSUs and PSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate fair value					$ 684,400	$ 462,300	$ 694,900
2018 Plan | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares) | shares					53.1
2018 Employee Stock Purchase Plan | Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for issuance (in shares) | shares					10.3
Shares available for grant (in shares) | shares					6.3
Duration of offering period					24 months
Number of purchases periods | period					4
Duration of purchase periods					6 months
Shares issued (in shares) | shares					0.5	0.4	0.3
Weighted-average purchase price per share (in dollars per share) | $ / shares					$ 106.46	$ 99.59	$ 108.61
Cash proceeds from the issuance of common stock					$ 52,000	$ 42,300	$ 34,600
Accrued compensation					$ 8,800	$ 7,400
Incremental stock-based compensation	$ 2,700		$ 8,300
2018 Employee Stock Purchase Plan | Employee Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average	18 months		18 months
2018 Employee Stock Purchase Plan | Employee Stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost, weighted-average			6 months

Stock-Based Compensation - Sche

Stock-Based Compensation - Schedule of Stock Options (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Outstanding Stock Options
Beginning balance (in shares)	1,267
Granted (in shares)	50
Exercised (in shares)	(864)
Canceled, forfeited or expired (in shares)	0
Ending balance (in shares)	453	1,267
Exercisable and expected to vest (in shares)	367	1,210
Weighted-Average Exercise Price
Beginning balance (in dollars per share)	$ 18.54
Granted (in dollars per share)	198.03
Exercised (in dollars per share)	14.17
Canceled, forfeited or expired (in dollars per share)	0
Ending balance (in dollars per share)	46.72	$ 18.54
Exercisable and expected to vest (in dollars per share)	$ 15.84	$ 12.82
Weighted-Average Remaining Contractual Term (in years)
Options outstanding, weighted average remaining contractual term	2 years 6 months	2 years 1 month 6 days
Exercisable and expected to vest, weighted average remaining contractual term	1 year	1 year 9 months 18 days
Options outstanding, aggregate intrinsic value	$ 60,923	$ 179,678
Exercised, aggregate intrinsic value	157,832	56,500	$ 230,100
Exercisable and expected to vest, aggregate intrinsic value	$ 59,989	$ 178,616

Stock-Based Compensation - Sc_2

Stock-Based Compensation - Schedule of Valuation Assumptions (Details) - shares shares in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)	50
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years	6 years 1 month 6 days
Expected stock price volatility	59.50%	58.20%
Risk-free interest rate	4.20%	3.90%
Dividend yield	0%	0%
Employee Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected stock price volatility, minimum	42.50%	58.10%	44.10%
Expected stock price volatility, maximum	64.80%	75.90%	79.40%
Risk-free interest rate, minimum	4.40%	4.20%	0.10%
Risk-free interest rate, maximum	5.40%	5.30%	3.20%
Dividend yield	0%	0%	0%
Employee Stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months	6 months	6 months
Employee Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years	2 years	2 years

Stock-Based Compensation - Sc_3

Stock-Based Compensation - Schedule of RSU and PSA Activity (Details) - RSUs and PSAs $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jul. 31, 2024 USD ($) $ / shares shares
Underlying Shares
Beginning balance (in shares) | shares	9,351
Granted (in shares) | shares	6,018
Vested (in shares) | shares	(3,624)
Canceled or forfeited (in shares) | shares	(1,931)
Ending balance (in shares) | shares	9,814
Weighted-Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 139.95
Granted (in dollars per share) | $ / shares	181.24
Vested (in dollars per share) | $ / shares	136.82
Canceled or forfeited (in dollars per share) | $ / shares	160.35
Ending balance (in dollars per share) | $ / shares	$ 162.41
Aggregate Intrinsic Value
Beginning balance | $	$ 1,499,714
Vested | $	684,393
Ending balance | $	$ 1,760,079

Stock-Based Compensation - Sc_4

Stock-Based Compensation - Schedule of Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 527,676	$ 444,834	$ 409,562
Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	50,820	39,168	23,847
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	219,096	215,597	191,091
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	180,554	117,915	118,299
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	77,206	71,118	76,325
Restructuring and other charges
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Stock-based compensation expense	$ 0	$ 1,036	$ 0

Common Stock - Narrative (Detai

Common Stock - Narrative (Details)	Jul. 31, 2024 vote
Equity [Abstract]
Number of votes per share	1

Common Stock - Schedule of Comm

Common Stock - Schedule of Common Stock (Details) - shares shares in Thousands	Jul. 31, 2024	Jul. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards outstanding (in shares)	453	1,267
Equity awards available for future grants (in shares)	56,161
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards outstanding (in shares)	453
Unvested RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards outstanding (in shares)	8,805
Committed unvested PSAs, based on the target number of shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards outstanding (in shares)	607
Unvested PSAs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards outstanding (in shares)	1,009
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards outstanding (in shares)	514
Equity awards available for future grants (in shares)	6,255
2018 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards available for future grants (in shares)	30,892
Stock reserved for settlement of the Notes
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Equity awards available for future grants (in shares)	7,626

Income Taxes - Schedule of Inco

Income Taxes - Schedule of Income before Income (Loss) Tax, Domestic and Foreign (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Domestic	$ (112,758)	$ (228,715)	$ (413,148)
International	83,529	46,151	29,518
Loss before income taxes	$ (29,229)	$ (182,564)	$ (383,630)

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Provision of Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Current:
Federal	$ 203	$ 1,091	$ 0
State	1,337	3,890	399
Foreign	32,620	14,438	6,996
Total current tax expense	34,160	19,419	7,395
Deferred:
Federal	(4,526)	0	(858)
State	(693)	0	(185)
Foreign	(464)	352	296
Total deferred tax benefit (expense)	(5,683)	352	(747)
Total provision for income taxes	$ 28,477	$ 19,771	$ 6,648

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Operating Loss Carryforwards [Line Items]
Tax benefits on total stock-based compensation expense	$ 23,000,000	$ 13,400,000	$ 1,400,000
Income tax benefit	(28,477,000)	(19,771,000)	(6,648,000)
Change during the period	162,527,000	117,465,000	208,160,000
Unrecognized tax benefits	63,925,000	40,689,000	29,699,000
Unrecognized tax benefits that impact effective tax rate	2,900,000
Federal Jurisdiction
Operating Loss Carryforwards [Line Items]
Operating loss carryforward	1,497,600,000
Federal Jurisdiction | Research Tax Credit Carryforward
Operating Loss Carryforwards [Line Items]
Tax credit carryforward	133,400,000
State Jurisdiction
Operating Loss Carryforwards [Line Items]
Operating loss carryforward	630,800,000
Operating loss carryforward, subject to expiration	554,900,000
Operating loss carryforward, not subject to expiration	75,900,000
State Jurisdiction | Research Tax Credit Carryforward
Operating Loss Carryforwards [Line Items]
Tax credit carryforward	73,900,000
Foreign Tax Authority
Operating Loss Carryforwards [Line Items]
Operating loss carryforward	75,600,000
Foreign Tax Authority | Research Tax Credit Carryforward
Operating Loss Carryforwards [Line Items]
Tax credit carryforward	1,900,000
Business Combination Deferred Taxes
Operating Loss Carryforwards [Line Items]
Income tax benefit	$ 5,200,000	$ 0	$ 1,000,000

Income Taxes - Schedule of Reco

Income Taxes - Schedule of Reconciliation of Effective Income Tax Rate (Details)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
Tax at federal statutory rate	21%	21%	21%
State taxes	(0.40%)	(2.10%)	(0.10%)
Impact of foreign rate differential	36.20%	10.10%	(0.40%)
Stock-based compensation	162.60%	(0.80%)	17.60%
U.S. tax credits	101.80%	8.60%	3.90%
Change in valuation allowance	(471.30%)	(34.10%)	(43.60%)
Withholding tax	(12.50%)	(1.30%)	(0.20%)
Waived deductions under Section 59A	74.30%	(11.80%)	0%
Transaction costs	(1.30%)	0%	0%
Meals and entertainment	(7.00%)	(0.80%)	(0.20%)
Other	(0.80%)	0.30%	0.30%
Effective tax rate	(97.40%)	(10.90%)	(1.70%)

Income Taxes - Schedule of Co_2

Income Taxes - Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2021
Deferred tax assets:
Net operating losses carryovers	$ 373,611	$ 401,261
Deferred revenue	181,654	122,326
Research and development capitalization	168,918	92,901
Tax credits carryovers	157,861	98,564
Other	100,930	75,641
Gross deferred tax assets	982,974	790,693
Less: Valuation allowance	(833,908)	(671,381)	$ (553,916)	$ (345,756)
Total deferred tax assets	149,066	119,312
Deferred tax liabilities:
Intangible assets	(10,273)	(4,765)
Deferred contract acquisition costs	(99,123)	(86,805)
Property and equipment	(9,929)	(4,690)
Operating lease right-of-use assets	(29,137)	(22,403)
Total deferred tax liabilities	(148,462)	(118,663)
Net deferred tax assets	$ 604	$ 649

Income Taxes - Schedule of Valu

Income Taxes - Schedule of Valuation Allowance (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance as of the beginning of the period	$ 671,381	$ 553,916	$ 345,756
Change during the period	162,527	117,465	208,160
Balance as of the end of the period	$ 833,908	$ 671,381	$ 553,916

Income Taxes - Schedule of Unre

Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Beginning balance	$ 40,689	$ 29,699
Gross increase for tax positions of prior years	6,960	1,653
Gross (decrease) for tax positions of prior years	(2,102)	0
Gross increase for tax positions of current year	18,378	9,337
Ending balance	$ 63,925	$ 40,689

Net Loss Per Share - Schedule o

Net Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Earnings Per Share [Abstract]
Net loss, basic	$ (57,706)	$ (202,335)	$ (390,278)
Net loss, diluted	$ (57,706)	$ (202,335)	$ (390,278)
Weighted-average shares used in computing net loss per share, basic (in shares)	149,586	144,942	140,895
Weighted-average shares used in computing net loss per share, diluted (in shares)	149,586	144,942	140,895
Net loss per share, basic (in dollars per share)	$ (0.39)	$ (1.40)	$ (2.77)
Net loss per share, diluted (in dollars per share)	$ (0.39)	$ (1.40)	$ (2.77)

Net Loss Per Share- Narrative (

Net Loss Per Share- Narrative (Details) - $ / shares	Jul. 31, 2024	Jun. 25, 2020
Earnings Per Share [Abstract]
Conversion price (in dollars per share)	$ 150.80	$ 150.80

Net Loss Per Share - Schedule_2

Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) shares in Thousands			12 Months Ended
	Aug. 01, 2022 shares	Jun. 25, 2020 shares $ / shares	Jul. 31, 2024 shares $ / shares	Jul. 31, 2023 shares	Jul. 31, 2022 shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)			18,800	19,466	17,750
Number of shares if notes converted (in shares)	7,630	7,626	7,600
Conversion price (in dollars per share) | $ / shares		$ 150.80	$ 150.80
Unvested RSUs and shares of common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)			9,198	8,442	6,769
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)			453	1,267	1,673
Unvested PSAs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)			1,009	1,012	832
Number of unvested PSAs as a percentage of target			100%
Share purchase rights under the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)			514	1,119	850
Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities (in shares)			7,626	7,626	7,626

Segment and Geographic Inform_3

Segment and Geographic Information - Narrative (Details)	12 Months Ended
	Jul. 31, 2024 segment
Risks and Uncertainties [Abstract]
Number of operating segments	1

Segment and Geographic Inform_4

Segment and Geographic Information - Schedule of Long-lived Assets (Details) - USD ($) $ in Thousands	Jul. 31, 2024	Jul. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	$ 472,881	$ 313,026
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	325,146	213,611
Rest of the world
Revenues from External Customers and Long-Lived Assets [Line Items]
Total	$ 147,735	$ 99,415